<?xml version="1.0" encoding="utf-8"?>
<iati-activities version="2.03" generated-datetime="2026-11-11T15:32:23+00:00">
  <iati-activity last-updated-datetime="2026-11-10T13:42:47+00:00" xml:lang="en" default-currency="USD" humanitarian="0" hierarchy="1">
    <iati-identifier>47045-SOM-T-WV-1</iati-identifier>
    <reporting-org ref="47045" type="30">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </reporting-org>
    <title>
      <narrative>Tuberculosis - Somalia (01-Jan-2012-31-Dec-2013)</narrative>
    </title>
    <description type="1">
      <narrative>Somalia, Tuberculosis, World Vision International</narrative>
    </description>
    <participating-org ref="47045" type="30" role="1" crs-channel-code="47045">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </participating-org>
    <participating-org type="21" role="2" crs-channel-code="21000">
      <narrative>World Vision International</narrative>
    </participating-org>
    <participating-org type="21" role="4" crs-channel-code="21000">
      <narrative>World Vision International</narrative>
    </participating-org>
    <other-identifier ref="SOM-T-WVP01" type="A1">
      <owner-org ref="47045">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </owner-org>
    </other-identifier>
    <activity-status code="4" />
    <activity-date type="1" iso-date="2012-01-01" />
    <activity-date type="2" iso-date="2012-01-01" />
    <activity-date type="3" iso-date="2013-12-31" />
    <activity-date type="4" iso-date="2013-12-31" />
    <contact-info type="1">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Communications</narrative>
      </department>
      <telephone>+41 58 791 1700</telephone>
      <email>website@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <contact-info type="2">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Grant Management Division</narrative>
      </department>
      <person-name>
        <narrative>Amélie Joubert</narrative>
      </person-name>
      <job-title>
        <narrative>Fund Portfolio Manager</narrative>
      </job-title>
      <telephone>+41 58 791 1700</telephone>
      <email>amelie.joubert@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <activity-scope code="4" />
    <recipient-country code="SO" percentage="100">
      <narrative>Somalia</narrative>
    </recipient-country>
    <sector vocabulary="1" code="12263" percentage="100">
      <narrative>Tuberculosis</narrative>
    </sector>
    <tag vocabulary="2" code="3">
      <narrative>Ensure healthy lives and promote well-being for all at all ages</narrative>
    </tag>
    <tag vocabulary="3" code="3.3">
      <narrative>End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases</narrative>
    </tag>
    <collaboration-type code="1" />
    <default-flow-type code="10" />
    <default-finance-type code="110" />
    <default-aid-type code="C01" vocabulary="1" />
    <default-tied-status code="5" />
    <transaction ref="6343554f-7c8e-41f2-bf31-45e7c2f9462c">
      <transaction-type code="3" />
      <transaction-date iso-date="2012-01-26" />
      <value currency="USD" value-date="2012-01-26">5402819.00</value>
      <description>
        <narrative>Global Fund disbursement to SOM-T-WVP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="4e0510f6-7407-4425-ac95-1cc78fa573fd">
      <transaction-type code="3" />
      <transaction-date iso-date="2012-06-27" />
      <value currency="USD" value-date="2012-06-27">835019.84</value>
      <description>
        <narrative>Global Fund disbursement to SOM-T-WVP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="a30eeb27-90b5-4a16-ae77-828416b50077">
      <transaction-type code="3" />
      <transaction-date iso-date="2012-09-27" />
      <value currency="USD" value-date="2012-09-27">3265904.00</value>
      <description>
        <narrative>Global Fund disbursement to SOM-T-WVP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="8cb0e49c-526b-49ba-ab2f-eca078775955">
      <transaction-type code="3" />
      <transaction-date iso-date="2013-05-08" />
      <value currency="USD" value-date="2013-05-08">4116434.00</value>
      <description>
        <narrative>Global Fund disbursement to SOM-T-WVP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="0e0afe7a-a2ef-4c32-b2d9-3c4d9d38bce4">
      <transaction-type code="3" />
      <transaction-date iso-date="2013-10-24" />
      <value currency="USD" value-date="2013-10-24">902676.00</value>
      <description>
        <narrative>Global Fund disbursement to SOM-T-WVP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="c4fc09b2-aaee-44f3-b2e3-d6e4cb3e2e49">
      <transaction-type code="3" />
      <transaction-date iso-date="2013-10-24" />
      <value currency="USD" value-date="2013-10-24">3766288.00</value>
      <description>
        <narrative>Global Fund disbursement to SOM-T-WVP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="94fee3ee-52eb-4ec9-9cf2-d3c36286f3a5">
      <transaction-type code="2" />
      <transaction-date iso-date="2014-01-16" />
      <value currency="USD" value-date="2014-01-16">19136835.00</value>
      <description>
        <narrative>Global Fund commitment to SOM-T-WVP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="565251ef-8b85-4fa1-8bbf-60f4f8032e0c">
      <transaction-type code="2" />
      <transaction-date iso-date="2014-05-05" />
      <value currency="USD" value-date="2014-05-05">-847694.16</value>
      <description>
        <narrative>Global Fund commitment to SOM-T-WVP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
    </transaction>
    <document-link url="https://data.theglobalfund.org/grant/SOM-T-WV" format="text/html">
      <title>
        <narrative>Grant page on the data explorer of the Global Fund.</narrative>
      </title>
      <description>
        <narrative>An overview of a grant over its lifetime.</narrative>
      </description>
      <category code="A12" />
      <category code="A01" />
      <category code="A02" />
      <category code="A05" />
      <category code="A07" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2026-11-11" />
    </document-link>
    <document-link url="https://www.theglobalfund.org/media/13342/core_grantregulationsversiontwo_regulations_en.pdf" format="application/pdf">
      <title>
        <narrative>Grant terms and conditions.</narrative>
      </title>
      <description>
        <narrative>General terms and conditions which apply to Global Fund grants.</narrative>
      </description>
      <category code="A04" />
      <language code="en" />
    </document-link>
  </iati-activity>
  <iati-activity last-updated-datetime="2026-11-10T13:42:47+00:00" xml:lang="en" default-currency="USD" humanitarian="0" hierarchy="1">
    <iati-identifier>47045-SOM-T-WV-2</iati-identifier>
    <reporting-org ref="47045" type="30">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </reporting-org>
    <title>
      <narrative>To decrease the burden of tuberculosis in Somalia - Somalia (01-Jan-2014-31-Dec-2017)</narrative>
    </title>
    <description type="1">
      <narrative>Tuberculosis (TB) is a public health emergency in Somalia. The estimated incidence is extremely high at 160/100,000 for sputum smears positive TB cases, while the prevalence is estimated at 290/100,000 (WHO Global TB Report 2009).  The long-standing complex emergency combined with natural disasters has negatively affected the TB epidemiology. The goal of the Program is to decrease the burden of TB in Somalia with emphasis on accessibility, affordability, quality, equity, sustainability and patient satisfaction in line with the Millenium Development Goals and the global Stop TB Partnership targets. The Program targets people suffering from TB (including multi drug resistant TB (MDR TB) patients); their healthy contacts, including families, neighbors and health staff; and internally displaced persons, refugees, prisoners and military personnel. This Program is a consolidation of Round 10 and Round 7 TB grants.</narrative>
    </description>
    <description type="2">
      <narrative>Goal: To reduce the incidence rate of all forms of TB in Somalia by 10% by 2019. Objectives: To identify at least 900 new MDR-TB cases by 2017 and at least 1500 and successfully treat 70% of them by 2019; To increase the annual number of notified cases of all forms of TB to 20,000 and successfully treats at least 95% of them by 2019; To strengthen the management and capacity of the National TB Programms and partners for effective management of Tuberculosis control.</narrative>
    </description>
    <participating-org ref="47045" type="30" role="1" crs-channel-code="47045">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </participating-org>
    <participating-org type="21" role="2" crs-channel-code="21000">
      <narrative>World Vision International</narrative>
    </participating-org>
    <participating-org type="21" role="4" crs-channel-code="21000">
      <narrative>World Vision International</narrative>
    </participating-org>
    <other-identifier ref="SOM-T-WVP02" type="A1">
      <owner-org ref="47045">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </owner-org>
    </other-identifier>
    <activity-status code="4" />
    <activity-date type="1" iso-date="2014-01-01" />
    <activity-date type="2" iso-date="2014-01-01" />
    <activity-date type="3" iso-date="2017-12-31" />
    <activity-date type="4" iso-date="2017-12-31" />
    <contact-info type="1">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Communications</narrative>
      </department>
      <telephone>+41 58 791 1700</telephone>
      <email>website@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <contact-info type="2">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Grant Management Division</narrative>
      </department>
      <person-name>
        <narrative>Amélie Joubert</narrative>
      </person-name>
      <job-title>
        <narrative>Fund Portfolio Manager</narrative>
      </job-title>
      <telephone>+41 58 791 1700</telephone>
      <email>amelie.joubert@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <activity-scope code="4" />
    <recipient-country code="SO" percentage="100">
      <narrative>Somalia</narrative>
    </recipient-country>
    <sector vocabulary="1" code="12263" percentage="100">
      <narrative>Tuberculosis</narrative>
    </sector>
    <tag vocabulary="2" code="3">
      <narrative>Ensure healthy lives and promote well-being for all at all ages</narrative>
    </tag>
    <tag vocabulary="3" code="3.3">
      <narrative>End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases</narrative>
    </tag>
    <collaboration-type code="1" />
    <default-flow-type code="10" />
    <default-finance-type code="110" />
    <default-aid-type code="C01" vocabulary="1" />
    <default-tied-status code="5" />
    <transaction ref="8e69cf97-85fc-4d7b-aaae-0c7c0eb9757e">
      <transaction-type code="2" />
      <transaction-date iso-date="2014-07-28" />
      <value currency="USD" value-date="2014-07-28">10377831.00</value>
      <description>
        <narrative>Global Fund commitment to SOM-T-WVP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="72a50657-594e-4aba-aaec-bac111eb7cd4">
      <transaction-type code="3" />
      <transaction-date iso-date="2014-07-31" />
      <value currency="USD" value-date="2014-07-31">25000.00</value>
      <description>
        <narrative>Global Fund disbursement to SOM-T-WVP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="c0e9123a-7c7a-4fdb-a356-f9490aaf628c">
      <transaction-type code="3" />
      <transaction-date iso-date="2014-07-31" />
      <value currency="USD" value-date="2014-07-31">4372809.00</value>
      <description>
        <narrative>Global Fund disbursement to SOM-T-WVP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="ee95bab2-8d2c-4aeb-80e3-e0334c7e7c66">
      <transaction-type code="3" />
      <transaction-date iso-date="2014-07-31" />
      <value currency="USD" value-date="2014-07-31">505317.00</value>
      <description>
        <narrative>Global Fund disbursement to SOM-T-WVP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="34b676e3-60d0-4d76-949d-0443fddc44d8">
      <transaction-type code="3" />
      <transaction-date iso-date="2015-03-13" />
      <value currency="USD" value-date="2015-03-13">344280.00</value>
      <description>
        <narrative>Global Fund disbursement to SOM-T-WVP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="4668e2a8-54f6-4a7a-a1f9-660fd68f4f18">
      <transaction-type code="3" />
      <transaction-date iso-date="2015-03-13" />
      <value currency="USD" value-date="2015-03-13">1700522.50</value>
      <description>
        <narrative>Global Fund disbursement to SOM-T-WVP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="3257f242-e8b4-43a7-9e77-bcae42cf7ba5">
      <transaction-type code="2" />
      <transaction-date iso-date="2015-05-26" />
      <value currency="USD" value-date="2015-05-26">-3429902.50</value>
      <description>
        <narrative>Global Fund commitment to SOM-T-WVP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="a6a426d4-31ef-4008-a76c-d366f56ea184">
      <transaction-type code="2" />
      <transaction-date iso-date="2015-05-26" />
      <value currency="USD" value-date="2015-05-26">11453343.00</value>
      <description>
        <narrative>Global Fund commitment to SOM-T-WVP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="29e29d62-d01e-4ed3-9bcf-4440f5baf6ad">
      <transaction-type code="3" />
      <transaction-date iso-date="2015-05-27" />
      <value currency="USD" value-date="2015-05-27">229520.00</value>
      <description>
        <narrative>Global Fund disbursement to SOM-T-WVP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="4507a920-8f9f-4caf-8f19-adcf21b252fe">
      <transaction-type code="3" />
      <transaction-date iso-date="2015-05-27" />
      <value currency="USD" value-date="2015-05-27">4581637.00</value>
      <description>
        <narrative>Global Fund disbursement to SOM-T-WVP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="94a406e4-9b18-46d8-b85f-09ff3ea4a392">
      <transaction-type code="3" />
      <transaction-date iso-date="2015-05-27" />
      <value currency="USD" value-date="2015-05-27">25000.00</value>
      <description>
        <narrative>Global Fund disbursement to SOM-T-WVP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="8a1ae635-470c-408f-9645-845d09537731">
      <transaction-type code="3" />
      <transaction-date iso-date="2015-07-27" />
      <value currency="USD" value-date="2015-07-27">2255080.00</value>
      <description>
        <narrative>Global Fund disbursement to SOM-T-WVP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="2ce290e2-0096-478d-abaf-d6d94d8b0ee0">
      <transaction-type code="3" />
      <transaction-date iso-date="2015-12-04" />
      <value currency="USD" value-date="2015-12-04">2319584.00</value>
      <description>
        <narrative>Global Fund disbursement to SOM-T-WVP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="faa08ffd-a5d3-4978-aa92-9d490f3d1a4a">
      <transaction-type code="3" />
      <transaction-date iso-date="2016-02-12" />
      <value currency="USD" value-date="2016-02-12">679570.31</value>
      <description>
        <narrative>Global Fund disbursement to SOM-T-WVP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="24588d2b-cdef-4896-bb1b-2fe54056e46a">
      <transaction-type code="2" />
      <transaction-date iso-date="2016-07-11" />
      <value currency="USD" value-date="2016-07-11">11881481.00</value>
      <description>
        <narrative>Global Fund commitment to SOM-T-WVP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="d9e07da1-3afe-4a6b-be46-6bbda439a1f6">
      <transaction-type code="2" />
      <transaction-date iso-date="2016-07-11" />
      <value currency="USD" value-date="2016-07-11">-1362951.69</value>
      <description>
        <narrative>Global Fund commitment to SOM-T-WVP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="5e75849a-f965-4f08-b5b5-3e1764d36c58">
      <transaction-type code="3" />
      <transaction-date iso-date="2016-07-12" />
      <value currency="USD" value-date="2016-07-12">5900890.00</value>
      <description>
        <narrative>Global Fund disbursement to SOM-T-WVP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="0e3c8177-88bf-4a3f-b8dd-510c286e1b0f">
      <transaction-type code="3" />
      <transaction-date iso-date="2017-02-07" />
      <value currency="USD" value-date="2017-02-07">2526970.00</value>
      <description>
        <narrative>Global Fund disbursement to SOM-T-WVP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="29f8f91a-156f-405d-b3a6-54fa1c695894">
      <transaction-type code="2" />
      <transaction-date iso-date="2017-07-19" />
      <value currency="USD" value-date="2017-07-19">-3453621.00</value>
      <description>
        <narrative>Global Fund commitment to SOM-T-WVP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="fa8a9bbb-5a35-4d2a-b009-45c09616c7a7">
      <transaction-type code="2" />
      <transaction-date iso-date="2017-07-19" />
      <value currency="USD" value-date="2017-07-19">6123482.00</value>
      <description>
        <narrative>Global Fund commitment to SOM-T-WVP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="d5a5c46d-db09-47ab-b3ad-a7def17f76bf">
      <transaction-type code="3" />
      <transaction-date iso-date="2017-07-20" />
      <value currency="USD" value-date="2017-07-20">3980901.00</value>
      <description>
        <narrative>Global Fund disbursement to SOM-T-WVP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="b18377ab-f7ec-4fb9-823b-5d50094f4a57">
      <transaction-type code="3" />
      <transaction-date iso-date="2017-10-17" />
      <value currency="USD" value-date="2017-10-17">2142581.00</value>
      <description>
        <narrative>Global Fund disbursement to SOM-T-WVP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="29d73ffd-0d40-4990-9b21-dc255f77d4fb">
      <transaction-type code="2" />
      <transaction-date iso-date="2017-11-20" />
      <value currency="USD" value-date="2017-11-20">4438569.00</value>
      <description>
        <narrative>Global Fund commitment to SOM-T-WVP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="99fdb171-b92f-4915-be58-90682e25b7b3">
      <transaction-type code="3" />
      <transaction-date iso-date="2017-11-21" />
      <value currency="USD" value-date="2017-11-21">1573434.00</value>
      <description>
        <narrative>Global Fund disbursement to SOM-T-WVP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="63ab6384-0d52-461c-a51a-08eef59ce2f0">
      <transaction-type code="3" />
      <transaction-date iso-date="2017-12-07" />
      <value currency="USD" value-date="2017-12-07">2648843.00</value>
      <description>
        <narrative>Global Fund disbursement to SOM-T-WVP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="9a0edcda-6636-4011-bd20-10510b6f1580">
      <transaction-type code="2" />
      <transaction-date iso-date="2017-12-15" />
      <value currency="USD" value-date="2017-12-15">50000.00</value>
      <description>
        <narrative>Global Fund commitment to SOM-T-WVP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="15b15e22-e2a1-455e-82e3-5cee456c57ca">
      <transaction-type code="2" />
      <transaction-date iso-date="2018-03-16" />
      <value currency="USD" value-date="2018-03-16">-50000.00</value>
      <description>
        <narrative>Global Fund commitment to SOM-T-WVP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="2d277c1c-74a0-4b7f-82cc-58b5553037d0">
      <transaction-type code="3" />
      <transaction-date iso-date="2018-05-18" />
      <value currency="USD" value-date="2018-05-18">216292.00</value>
      <description>
        <narrative>Global Fund disbursement to SOM-T-WVP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="26a902fa-2888-4833-88ce-8d39e081cf6e">
      <transaction-type code="7" />
      <transaction-date iso-date="2019-01-25" />
      <value currency="USD" value-date="2019-01-25">72668.00</value>
      <description>
        <narrative>Funds returned to the Global Fund from SOM-T-WVP02.</narrative>
      </description>
      <provider-org type="21">
        <narrative>World Vision International</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="76bc6c6c-5d45-4f79-b39a-2eb972f3651d">
      <transaction-type code="2" />
      <transaction-date iso-date="2019-01-30" />
      <value currency="USD" value-date="2019-01-30">-72668.00</value>
      <description>
        <narrative>Global Fund commitment to SOM-T-WVP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
    </transaction>
    <document-link url="https://data.theglobalfund.org/grant/SOM-T-WV" format="text/html">
      <title>
        <narrative>Grant page on the data explorer of the Global Fund.</narrative>
      </title>
      <description>
        <narrative>An overview of a grant over its lifetime.</narrative>
      </description>
      <category code="A12" />
      <category code="A01" />
      <category code="A02" />
      <category code="A05" />
      <category code="A07" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2026-11-11" />
    </document-link>
    <document-link url="https://www.theglobalfund.org/media/13342/core_grantregulationsversiontwo_regulations_en.pdf" format="application/pdf">
      <title>
        <narrative>Grant terms and conditions.</narrative>
      </title>
      <description>
        <narrative>General terms and conditions which apply to Global Fund grants.</narrative>
      </description>
      <category code="A04" />
      <language code="en" />
    </document-link>
  </iati-activity>
  <iati-activity last-updated-datetime="2026-11-10T13:42:47+00:00" xml:lang="en" default-currency="USD" humanitarian="0" hierarchy="1">
    <iati-identifier>47045-SOM-T-WV-3</iati-identifier>
    <reporting-org ref="47045" type="30">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </reporting-org>
    <title>
      <narrative>Reducing TB incidence and TB related mortality among Somalis - Somalia (01-Jan-2018-31-Dec-2020)</narrative>
    </title>
    <description type="1">
      <narrative>Somalia, Tuberculosis, World Vision International</narrative>
    </description>
    <description type="2">
      <narrative>Goal: Reduce the incidence of TB (all forms) by 50% by 2025 and 90% by 2035 (from 2015 baseline figure). Objectives: Increase TB treatment coverage (case detection ratio) to 54% by 2020 (from baseline of 47% in 2015); Increase treatment success to at least 90% in all forms of detected non-MDR TB cases; Increase annual case detection of MDR- TB to 700 by 2020 (from baseline of 243 in 2016) and improve management of MDR-TB cases through country-wide implementation of the shorter MDR-TB treatment regimen; Ensure that 100% of new staff receive induction training and that 50% of TB service facilities receive regular supervision and monitoring by 2022.</narrative>
    </description>
    <participating-org ref="47045" type="30" role="1" crs-channel-code="47045">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </participating-org>
    <participating-org type="21" role="2" crs-channel-code="21000">
      <narrative>World Vision International</narrative>
    </participating-org>
    <participating-org type="21" role="4" crs-channel-code="21000">
      <narrative>World Vision International</narrative>
    </participating-org>
    <other-identifier ref="SOM-T-WVP03" type="A1">
      <owner-org ref="47045">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </owner-org>
    </other-identifier>
    <activity-status code="4" />
    <activity-date type="1" iso-date="2018-01-01" />
    <activity-date type="2" iso-date="2018-01-01" />
    <activity-date type="3" iso-date="2020-12-31" />
    <activity-date type="4" iso-date="2020-12-31" />
    <contact-info type="1">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Communications</narrative>
      </department>
      <telephone>+41 58 791 1700</telephone>
      <email>website@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <contact-info type="2">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Grant Management Division</narrative>
      </department>
      <person-name>
        <narrative>Amélie Joubert</narrative>
      </person-name>
      <job-title>
        <narrative>Fund Portfolio Manager</narrative>
      </job-title>
      <telephone>+41 58 791 1700</telephone>
      <email>amelie.joubert@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <activity-scope code="4" />
    <recipient-country code="SO" percentage="100">
      <narrative>Somalia</narrative>
    </recipient-country>
    <sector vocabulary="1" code="12263" percentage="63.4">
      <narrative>Tuberculosis</narrative>
    </sector>
    <sector vocabulary="1" code="12110" percentage="36.6">
      <narrative>Multicomponent, RSSH</narrative>
    </sector>
    <tag vocabulary="2" code="3">
      <narrative>Ensure healthy lives and promote well-being for all at all ages</narrative>
    </tag>
    <tag vocabulary="3" code="3.3">
      <narrative>End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases</narrative>
    </tag>
    <tag vocabulary="3" code="3.8">
      <narrative>Achieve universal health coverage</narrative>
    </tag>
    <country-budget-items vocabulary="4">
      <budget-item code="955f4722-71fb-4b46-8bd2-2d741fdad76b" percentage="8.76">
        <description>
          <narrative>Multicomponent -&gt; Program management -&gt; Coordination and management of national disease control programs</narrative>
        </description>
      </budget-item>
      <budget-item code="e07bbbe4-54fa-4084-a6fe-7f1c9c3b77b6" percentage="23.63">
        <description>
          <narrative>Multicomponent -&gt; Program management -&gt; Grant management</narrative>
        </description>
      </budget-item>
      <budget-item code="5221e091-6641-4eee-b68d-9b5879a96a78" percentage="0.2">
        <description>
          <narrative>RSSH -&gt; RSSH: Health management information systems and M&amp;E -&gt; Routine reporting</narrative>
        </description>
      </budget-item>
      <budget-item code="f9be36a8-948e-4f4f-860d-8e162eeaa510" percentage="0.29">
        <description>
          <narrative>RSSH -&gt; RSSH: Health sector governance and planning -&gt; National health sector strategies and financing</narrative>
        </description>
      </budget-item>
      <budget-item code="054acddf-7eaa-4d8d-b6a4-97e7f6a59a1e" percentage="1.63">
        <description>
          <narrative>RSSH -&gt; RSSH: Human resources for health, including community health workers -&gt; Capacity building for health workers, including those at community level</narrative>
        </description>
      </budget-item>
      <budget-item code="a9a15642-9d30-4ac6-85fe-0d687727c2d2" percentage="2.08">
        <description>
          <narrative>RSSH -&gt; RSSH: Human resources for health, including community health workers -&gt; Retention and scale-up of health workers, including for community health workers</narrative>
        </description>
      </budget-item>
      <budget-item code="1c7b99cb-f18c-499f-a55d-f7a0d6b99b21" percentage="7.68">
        <description>
          <narrative>Tuberculosis -&gt; MDR-TB -&gt; Case detection and diagnosis (MDR-TB)</narrative>
        </description>
      </budget-item>
      <budget-item code="3637a37c-6acc-4a5b-b7e4-00640fd7e2ec" percentage="13.04">
        <description>
          <narrative>Tuberculosis -&gt; MDR-TB -&gt; Treatment (MDR-TB)</narrative>
        </description>
      </budget-item>
      <budget-item code="f7014493-22e9-4c03-96d0-144fbb3a254f" percentage="34.14">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Case detection and diagnosis (TB care and prevention)</narrative>
        </description>
      </budget-item>
      <budget-item code="1a563d22-2c21-4f9a-b142-805695850ac9" percentage="1.83">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Key populations (TB care and prevention) - Others</narrative>
        </description>
      </budget-item>
      <budget-item code="56afe3f2-1fa3-4fd3-b845-9ea07f4bfd51" percentage="0.12">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Key populations (TB care and prevention) - Prisoners</narrative>
        </description>
      </budget-item>
      <budget-item code="fbc19cfa-87a0-4ea9-b0f8-b510eb8eab13" percentage="0.01">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Other TB care and prevention intervention(s)</narrative>
        </description>
      </budget-item>
      <budget-item code="edbef7da-ca99-4741-8ce0-ea3ba6cd3d3b" percentage="5.11">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Treatment (TB care and prevention)</narrative>
        </description>
      </budget-item>
      <budget-item code="92e11022-488c-4948-abb3-b61f3d9ca4f6" percentage="1.48">
        <description>
          <narrative>Tuberculosis -&gt; TB/HIV -&gt; TB/HIV - Collaborative interventions</narrative>
        </description>
      </budget-item>
    </country-budget-items>
    <collaboration-type code="1" />
    <default-flow-type code="10" />
    <default-finance-type code="110" />
    <default-aid-type code="C01" vocabulary="1" />
    <default-tied-status code="5" />
    <budget type="2" status="2">
      <period-start iso-date="2018-01-01" />
      <period-end iso-date="2018-12-31" />
      <value currency="USD" value-date="2018-01-01">6413956.26</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2019-01-01" />
      <period-end iso-date="2019-12-31" />
      <value currency="USD" value-date="2019-01-01">7632901.71</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2020-01-01" />
      <period-end iso-date="2020-12-31" />
      <value currency="USD" value-date="2020-01-01">9583691.37</value>
    </budget>
    <capital-spend percentage="9.1" />
    <transaction ref="4dbba2f7-e035-4901-bff3-83598bfea6e7">
      <transaction-type code="2" />
      <transaction-date iso-date="2017-12-18" />
      <value currency="USD" value-date="2017-12-18">11183007.63</value>
      <description>
        <narrative>Global Fund commitment to SOM-T-WVP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="56870343-73ea-4512-baa7-dd2b442df64e">
      <transaction-type code="3" />
      <transaction-date iso-date="2018-01-09" />
      <value currency="USD" value-date="2018-01-09">1763191.00</value>
      <description>
        <narrative>Global Fund disbursement to SOM-T-WVP03 (International NGO).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="6289e01a-446b-469b-b778-4a3b12a959eb">
      <transaction-type code="2" />
      <transaction-date iso-date="2018-03-27" />
      <value currency="USD" value-date="2018-03-27">50000.00</value>
      <description>
        <narrative>Global Fund commitment to SOM-T-WVP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="f0692a62-0450-4631-bc66-e77fbdf83bfb">
      <transaction-type code="3" />
      <transaction-date iso-date="2018-08-14" />
      <value currency="USD" value-date="2018-08-14">3815028.00</value>
      <description>
        <narrative>Global Fund disbursement to SOM-T-WVP03 (International NGO).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="f32e23de-ff20-4f90-85ee-28aaea814dcd">
      <transaction-type code="3" />
      <transaction-date iso-date="2018-10-05" />
      <value currency="USD" value-date="2018-10-05">50000.00</value>
      <description>
        <narrative>Global Fund disbursement to SOM-T-WVP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="33503f28-5ede-4163-b8c5-c29e2a07c690">
      <transaction-type code="3" />
      <transaction-date iso-date="2018-11-06" />
      <value currency="USD" value-date="2018-11-06">1791082.00</value>
      <description>
        <narrative>Global Fund disbursement to SOM-T-WVP03 (International NGO).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="ec60c7c8-5b38-4e86-a279-74b585b4fb0d">
      <transaction-type code="3" />
      <transaction-date iso-date="2019-04-23" />
      <value currency="USD" value-date="2019-04-23">1280588.68</value>
      <description>
        <narrative>Global Fund disbursement to SOM-T-WVP03 (International NGO).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="dcdcf204-0e5e-4f12-9226-c654b8a7da7b">
      <transaction-type code="2" />
      <transaction-date iso-date="2019-05-07" />
      <value currency="USD" value-date="2019-05-07">50000.00</value>
      <description>
        <narrative>Global Fund commitment to SOM-T-WVP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="10ecee07-18ee-4acf-8917-7a4f38ed7ee2">
      <transaction-type code="2" />
      <transaction-date iso-date="2019-06-26" />
      <value currency="USD" value-date="2019-06-26">-2533117.95</value>
      <description>
        <narrative>Global Fund commitment to SOM-T-WVP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="1285289b-1ae0-4379-929f-cd5a4febfd2a">
      <transaction-type code="2" />
      <transaction-date iso-date="2019-06-26" />
      <value currency="USD" value-date="2019-06-26">10537581.65</value>
      <description>
        <narrative>Global Fund commitment to SOM-T-WVP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="e84c7550-a63c-4440-aebb-b09ce6b834c7">
      <transaction-type code="3" />
      <transaction-date iso-date="2019-06-27" />
      <value currency="USD" value-date="2019-06-27">2503863.65</value>
      <description>
        <narrative>Global Fund disbursement to SOM-T-WVP03 (International NGO).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="0bd080ba-1fd2-4365-a503-8314143a98ea">
      <transaction-type code="3" />
      <transaction-date iso-date="2019-08-22" />
      <value currency="USD" value-date="2019-08-22">1274690.00</value>
      <description>
        <narrative>Global Fund disbursement to SOM-T-WVP03 (International NGO).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="5f0d2f58-5fed-45fe-b280-c5991d4147f3">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-01-21" />
      <value currency="USD" value-date="2020-01-21">1370187.00</value>
      <description>
        <narrative>Global Fund disbursement to SOM-T-WVP03 (International NGO).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="ef5ec561-26d3-4bb2-835f-158b7bee3c09">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-02-06" />
      <value currency="USD" value-date="2020-02-06">1758588.00</value>
      <description>
        <narrative>Global Fund disbursement to SOM-T-WVP03 (International NGO).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="b655ae29-b12e-4fde-9f64-13b2b46500de">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-02-18" />
      <value currency="USD" value-date="2020-02-18">50000.00</value>
      <description>
        <narrative>Global Fund disbursement to SOM-T-WVP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="48402948-976d-426e-979c-4263b7eab9f8">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-05-13" />
      <value currency="USD" value-date="2020-05-13">354960.25</value>
      <description>
        <narrative>Global Fund disbursement to SOM-T-WVP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="88dca30a-88a4-4a07-bfb0-842752a606f9">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-05-13" />
      <value currency="USD" value-date="2020-05-13">2202544.75</value>
      <description>
        <narrative>Global Fund disbursement to SOM-T-WVP03 (International NGO).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="b821402a-cf32-4422-adc8-13649218e7ce">
      <transaction-type code="2" />
      <transaction-date iso-date="2020-05-15" />
      <value currency="USD" value-date="2020-05-15">50000.00</value>
      <description>
        <narrative>Global Fund commitment to SOM-T-WVP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="be143250-ce9f-4eac-a212-ac5cc70647e1">
      <transaction-type code="2" />
      <transaction-date iso-date="2020-06-06" />
      <value currency="USD" value-date="2020-06-06">98863.27</value>
      <description>
        <narrative>Global Fund commitment to SOM-T-WVP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="d24aae90-2086-4816-b406-4f33e6b51f82">
      <transaction-type code="2" />
      <transaction-date iso-date="2020-06-15" />
      <value currency="USD" value-date="2020-06-15">5266825.67</value>
      <description>
        <narrative>Global Fund commitment to SOM-T-WVP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="ed405cdb-db94-449c-97c8-8c2d50081baa">
      <transaction-type code="2" />
      <transaction-date iso-date="2020-06-15" />
      <value currency="USD" value-date="2020-06-15">-1072748.00</value>
      <description>
        <narrative>Global Fund commitment to SOM-T-WVP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="4f6ae987-516c-4539-b4f2-0032815e5dac">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-06-24" />
      <value currency="USD" value-date="2020-06-24">243253.63</value>
      <description>
        <narrative>Global Fund disbursement to SOM-T-WVP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="cf59d44a-e712-4934-8323-c6565a9a33f0">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-06-24" />
      <value currency="USD" value-date="2020-06-24">570242.00</value>
      <description>
        <narrative>Global Fund disbursement to SOM-T-WVP03 (International NGO).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="b77563a0-426f-4e0f-879f-8123c85c0444">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-07-08" />
      <value currency="USD" value-date="2020-07-08">45187.33</value>
      <description>
        <narrative>Global Fund disbursement to SOM-T-WVP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="273e136a-e04d-4e68-974e-610d9a493ffb">
      <transaction-type code="2" />
      <transaction-date iso-date="2020-07-25" />
      <value currency="USD" value-date="2020-07-25">97741.20</value>
      <description>
        <narrative>Global Fund commitment to SOM-T-WVP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="50a136dd-a5a5-46c9-92e2-efd5148ef56c">
      <transaction-type code="2" />
      <transaction-date iso-date="2020-07-25" />
      <value currency="USD" value-date="2020-07-25">-98863.27</value>
      <description>
        <narrative>Global Fund commitment to SOM-T-WVP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="12dcbb4a-a411-45da-a41c-340fe3efe51a">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-08-26" />
      <value currency="USD" value-date="2020-08-26">79419.90</value>
      <description>
        <narrative>Global Fund disbursement to SOM-T-WVP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="79e60e97-0527-4ad3-81f3-5479e6e6c210">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-09-02" />
      <value currency="USD" value-date="2020-09-02">216712.00</value>
      <description>
        <narrative>Global Fund disbursement to SOM-T-WVP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="395d0b4d-76b9-46ec-9466-017a8ef7439b">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-09-16" />
      <value currency="USD" value-date="2020-09-16">1166235.00</value>
      <description>
        <narrative>Global Fund disbursement to SOM-T-WVP03 (International NGO).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="6425c7e8-895c-41d9-840c-cc8fd44cef5b">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-09-28" />
      <value currency="USD" value-date="2020-09-28">94416.96</value>
      <description>
        <narrative>Global Fund disbursement to SOM-T-WVP03 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="6c6e0675-33a0-4c44-b913-d1b8c0eb4a08">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-10-21" />
      <value currency="USD" value-date="2020-10-21">1555315.00</value>
      <description>
        <narrative>Global Fund disbursement to SOM-T-WVP03 (International NGO).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="6a6a29fb-6bde-4ecd-851b-b7a7aa6ac8f4">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-11-11" />
      <value currency="USD" value-date="2020-11-11">2838.62</value>
      <description>
        <narrative>Global Fund disbursement to SOM-T-WVP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="dfabb816-b1be-40ab-ac91-5d5ce518d51d">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-12-16" />
      <value currency="USD" value-date="2020-12-16">5198.50</value>
      <description>
        <narrative>Global Fund disbursement to SOM-T-WVP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="57106c38-32a0-42ba-adc5-71522c795c3d">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-03-10" />
      <value currency="USD" value-date="2021-03-10">-3324.24</value>
      <description>
        <narrative>Global Fund commitment to SOM-T-WVP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="54548434-0ac9-43a7-b50c-641d914c9fb1">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-04-01" />
      <value currency="USD" value-date="2021-04-01">50000.00</value>
      <description>
        <narrative>Global Fund disbursement to SOM-T-WVP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="28d72a49-0709-4999-8dd1-f828d45a282a">
      <transaction-type code="7" />
      <transaction-date iso-date="2021-07-23" />
      <value currency="USD" value-date="2021-07-23">18159.00</value>
      <description>
        <narrative>Funds returned to the Global Fund from SOM-T-WVP03 (International NGO).</narrative>
      </description>
      <provider-org type="21">
        <narrative>World Vision International</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="c27476d9-d7b1-4065-84b1-2a6da29e8b5d">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-07-23" />
      <value currency="USD" value-date="2021-07-23">-18159.00</value>
      <description>
        <narrative>Global Fund commitment to SOM-T-WVP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="6eb4c8cd-9383-42f6-be18-89a9b93052a6">
      <transaction-type code="7" />
      <transaction-date iso-date="2021-09-01" />
      <value currency="USD" value-date="2021-09-01">2783.83</value>
      <description>
        <narrative>Funds returned to the Global Fund from SOM-T-WVP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="21">
        <narrative>World Vision International</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="fa6f0185-41ac-4669-b84d-910abfddb661">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-09-30" />
      <value currency="USD" value-date="2021-09-30">-2783.83</value>
      <description>
        <narrative>Global Fund commitment to SOM-T-WVP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="e679059c-abc8-4be1-9edf-0d6f26421a7a">
      <transaction-type code="7" />
      <transaction-date iso-date="2021-12-01" />
      <value currency="USD" value-date="2021-12-01">1376.31</value>
      <description>
        <narrative>Funds returned to the Global Fund from SOM-T-WVP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="21">
        <narrative>World Vision International</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="63c958f5-672c-4d21-b690-adb35763a224">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-12-07" />
      <value currency="USD" value-date="2021-12-07">-1376.31</value>
      <description>
        <narrative>Global Fund commitment to SOM-T-WVP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="a0a661eb-d8a0-4a3b-9cbe-f23d0b6a2f37">
      <transaction-type code="7" />
      <transaction-date iso-date="2021-12-16" />
      <value currency="USD" value-date="2021-12-16">411.02</value>
      <description>
        <narrative>Funds returned to the Global Fund from SOM-T-WVP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="21">
        <narrative>World Vision International</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="5d4c18ec-fe4f-40d6-b47f-16b48a2f91ad">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-12-20" />
      <value currency="USD" value-date="2021-12-20">-411.02</value>
      <description>
        <narrative>Global Fund commitment to SOM-T-WVP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="02d92790-9fc8-4f2f-9c1d-d367648ca771">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-05-20" />
      <value currency="USD" value-date="2022-05-20">-1382423.69</value>
      <description>
        <narrative>Global Fund commitment to SOM-T-WVP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="09cd6233-9f34-477e-92ec-382a9f8368ac">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-03-21" />
      <value currency="USD" value-date="2023-03-21">720013.01</value>
      <description>
        <narrative>Global Fund commitment to SOM-T-WVP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="515816c4-ae78-419f-81eb-90206518d85d">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-03-24" />
      <value currency="USD" value-date="2023-03-24">720013.01</value>
      <description>
        <narrative>Global Fund disbursement to SOM-T-WVP03 (International NGO).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="SOM-T-WVP03-EXP-20181231">
      <transaction-type code="4" />
      <transaction-date iso-date="2018-12-31" />
      <value currency="USD" value-date="2018-12-31">6413956.35</value>
      <description>
        <narrative>Expenditure reported by World Vision International for SOM-T-WVP03, Jan 2018 to Dec 2018.</narrative>
      </description>
      <provider-org type="21">
        <narrative>World Vision International</narrative>
      </provider-org>
    </transaction>
    <transaction ref="SOM-T-WVP03-EXP-20191231">
      <transaction-type code="4" />
      <transaction-date iso-date="2019-12-31" />
      <value currency="USD" value-date="2019-12-31">7632472.67</value>
      <description>
        <narrative>Expenditure reported by World Vision International for SOM-T-WVP03, Jan 2019 to Dec 2019.</narrative>
      </description>
      <provider-org type="21">
        <narrative>World Vision International</narrative>
      </provider-org>
    </transaction>
    <transaction ref="SOM-T-WVP03-EXP-20201231">
      <transaction-type code="4" />
      <transaction-date iso-date="2020-12-31" />
      <value currency="USD" value-date="2020-12-31">8923203.88</value>
      <description>
        <narrative>Expenditure reported by World Vision International for SOM-T-WVP03, Jan 2020 to Dec 2020.</narrative>
      </description>
      <provider-org type="21">
        <narrative>World Vision International</narrative>
      </provider-org>
    </transaction>
    <transaction ref="SOM-T-WVP03-EXP-20210630">
      <transaction-type code="4" />
      <transaction-date iso-date="2021-06-30" />
      <value currency="USD" value-date="2021-06-30">10893.04</value>
      <description>
        <narrative>Expenditure reported by World Vision International for SOM-T-WVP03, Jan 2021 to Jun 2021.</narrative>
      </description>
      <provider-org type="21">
        <narrative>World Vision International</narrative>
      </provider-org>
    </transaction>
    <document-link url="https://data.theglobalfund.org/grant/SOM-T-WV" format="text/html">
      <title>
        <narrative>Grant page on the data explorer of the Global Fund.</narrative>
      </title>
      <description>
        <narrative>An overview of a grant over its lifetime.</narrative>
      </description>
      <category code="A12" />
      <category code="A01" />
      <category code="A02" />
      <category code="A05" />
      <category code="A07" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2026-11-11" />
    </document-link>
    <document-link url="https://www.theglobalfund.org/media/13342/core_grantregulationsversiontwo_regulations_en.pdf" format="application/pdf">
      <title>
        <narrative>Grant terms and conditions.</narrative>
      </title>
      <description>
        <narrative>General terms and conditions which apply to Global Fund grants.</narrative>
      </description>
      <category code="A04" />
      <language code="en" />
    </document-link>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of TB cases with RR-TB and/or MDR-TB notified</narrative>
      </title>
      <description>
        <narrative>Module: MDR-TB.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of TB cases with RR-TB and/or MDR-TB notified</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2016" iso-date="2016-12-31" value="243" />
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-06-30" />
          <target value="225" />
          <actual value="158" />
        </period>
        <period>
          <period-start iso-date="2018-07-01" />
          <period-end iso-date="2018-12-31" />
          <target value="225" />
          <actual value="149" />
        </period>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-06-30" />
          <target value="300" />
          <actual value="207" />
        </period>
        <period>
          <period-start iso-date="2019-07-01" />
          <period-end iso-date="2019-12-31" />
          <target value="300" />
          <actual value="165" />
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-06-30" />
          <target value="375" />
          <actual value="144" />
        </period>
        <period>
          <period-start iso-date="2020-07-01" />
          <period-end iso-date="2020-12-31" />
          <target value="375" />
          <actual value="108" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative>
      </title>
      <description>
        <narrative>Module: MDR-TB.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2016" iso-date="2016-12-31">
          <comment>
            <narrative>Numerator: 243.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 225.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 225.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 225.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 225.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 9.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 9.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 9.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 9.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 69.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 69.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 69.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 69.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 165.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 165.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 165.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 165.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="TB regimen" value="New TB drugs" />
          <comment>
            <narrative>Numerator: 234.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="TB regimen" value="New TB drugs" />
          <comment>
            <narrative>Numerator: 234.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="TB regimen" value="New TB drugs" />
          <comment>
            <narrative>Numerator: 234.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 225.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 157.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-07-01" />
          <period-end iso-date="2018-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 225.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 149.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 139; Denominator: 149; Percentage: 93.3%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 10; Denominator: 149; Percentage: 6.7%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 54; Denominator: 149; Percentage: 36.2%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 95; Denominator: 149; Percentage: 63.8%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 300.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 204.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 193; Denominator: 204; Percentage: 94.6%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 11; Denominator: 204; Percentage: 5.4%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 67; Denominator: 204; Percentage: 32.8%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 137; Denominator: 204; Percentage: 67.2%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="TB regimen" value="New TB drugs" />
            <comment>
              <narrative>Numerator: 189; Denominator: 207; Percentage: 91.3%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-07-01" />
          <period-end iso-date="2019-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 300.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 165.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 375.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 144.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 130; Denominator: 144; Percentage: 90.3%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 14; Denominator: 144; Percentage: 9.7%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 40; Denominator: 144; Percentage: 27.8%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 104; Denominator: 144; Percentage: 72.2%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="TB regimen" value="New TB drugs" />
            <comment>
              <narrative>Numerator: 134; Denominator: 144; Percentage: 93.1%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-07-01" />
          <period-end iso-date="2020-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 375.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 108.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 104; Denominator: 108; Percentage: 96.3%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 4; Denominator: 108; Percentage: 3.7%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 40; Denominator: 108; Percentage: 37%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 68; Denominator: 108; Percentage: 63%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="TB regimen" value="New TB drugs" />
            <comment>
              <narrative>Numerator: 86; Denominator: 108; Percentage: 79.6%.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of HMIS or other routine reporting units submitting timely reports according to national guidelines</narrative>
      </title>
      <description>
        <narrative>Module: RSSH: Health management information systems and M&amp;E.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of HMIS or other routine reporting units submitting timely reports according to national guidelines</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2016" iso-date="2016-12-31" value="82.19">
          <comment>
            <narrative>Numerator: 60; Denominator: 73.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-06-30" />
          <target value="85.3">
            <comment>
              <narrative>Numerator: 81; Denominator: 95.</narrative>
            </comment>
          </target>
          <actual value="84.6">
            <comment>
              <narrative>Numerator: 77; Denominator: 91.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-07-01" />
          <period-end iso-date="2018-12-31" />
          <target value="85.3">
            <comment>
              <narrative>Numerator: 81; Denominator: 95.</narrative>
            </comment>
          </target>
          <actual value="97.9">
            <comment>
              <narrative>Numerator: 93; Denominator: 95.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-06-30" />
          <target value="94.7">
            <comment>
              <narrative>Numerator: 90; Denominator: 95.</narrative>
            </comment>
          </target>
          <actual value="93.7">
            <comment>
              <narrative>Numerator: 89; Denominator: 95.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-07-01" />
          <period-end iso-date="2019-12-31" />
          <target value="94.74">
            <comment>
              <narrative>Numerator: 90; Denominator: 95.</narrative>
            </comment>
          </target>
          <actual value="94.7">
            <comment>
              <narrative>Numerator: 90; Denominator: 95.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-06-30" />
          <target value="100">
            <comment>
              <narrative>Numerator: 95; Denominator: 95.</narrative>
            </comment>
          </target>
          <actual value="98.9">
            <comment>
              <narrative>Numerator: 94; Denominator: 95.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-07-01" />
          <period-end iso-date="2020-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 95; Denominator: 95.</narrative>
            </comment>
          </target>
          <actual value="98.9">
            <comment>
              <narrative>Numerator: 93; Denominator: 94.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of notified TB cases (all forms) contributed by non-national TB program providers - private/non-governmental facilities</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of notified TB cases (all forms) contributed by non-national TB program providers - private/non-governmental facilities</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2016" iso-date="2016-12-31">
          <comment>
            <narrative>Numerator: 1044.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 1100.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1063; Denominator: 1100; Percentage: 96.6%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-07-01" />
          <period-end iso-date="2018-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 1100.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 946.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 1200.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1276.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-07-01" />
          <period-end iso-date="2019-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 1200.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1151.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 1300.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1010.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-07-01" />
          <period-end iso-date="2020-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 1300.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1044.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2016" iso-date="2016-12-31">
          <comment>
            <narrative>Numerator: 14133.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 10792.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 10792.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 10792.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 10792.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 3341.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 3341.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 3341.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 3341.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Type of TB" value="Bacteriologically confirmed" />
          <comment>
            <narrative>Numerator: 14381.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Type of TB" value="Bacteriologically confirmed" />
          <comment>
            <narrative>Numerator: 14381.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Type of TB" value="Bacteriologically confirmed" />
          <comment>
            <narrative>Numerator: 14381.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Type of TB" value="Bacteriologically confirmed" />
          <comment>
            <narrative>Numerator: 14381.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 5592.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 5592.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 5592.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 5592.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 8541.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 8541.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 8541.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 8541.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="HIV test status" value="Negative" />
          <comment>
            <narrative>Numerator: 11393.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="HIV test status" value="Negative" />
          <comment>
            <narrative>Numerator: 11393.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="HIV test status" value="Negative" />
          <comment>
            <narrative>Numerator: 11393.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="HIV test status" value="Negative" />
          <comment>
            <narrative>Numerator: 11393.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="HIV test status" value="Not documented" />
          <comment>
            <narrative>Numerator: 2566.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="HIV test status" value="Not documented" />
          <comment>
            <narrative>Numerator: 2566.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="HIV test status" value="Not documented" />
          <comment>
            <narrative>Numerator: 2566.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="HIV test status" value="Not documented" />
          <comment>
            <narrative>Numerator: 2566.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 174.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 174.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 174.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 174.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 8850.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 8046; Denominator: 8850; Percentage: 90.9%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-07-01" />
          <period-end iso-date="2018-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 8850.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 8070.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 6293; Denominator: 8070; Percentage: 78%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 1682; Denominator: 8070; Percentage: 20.8%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Type of TB" value="Bacteriologically confirmed" />
            <comment>
              <narrative>Numerator: 3724; Denominator: 8070; Percentage: 46.1%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 3366; Denominator: 8070; Percentage: 41.7%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 4609; Denominator: 8070; Percentage: 57.1%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Negative" />
            <comment>
              <narrative>Numerator: 7993; Denominator: 8070; Percentage: 99%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Not documented" />
            <comment>
              <narrative>Numerator: 381; Denominator: 8070; Percentage: 4.7%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 77; Denominator: 8070; Percentage: 1%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 9250.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 8349.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 6541; Denominator: 8349; Percentage: 78.3%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 1764; Denominator: 8349; Percentage: 21.1%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Type of TB" value="Bacteriologically confirmed" />
            <comment>
              <narrative>Numerator: 6102; Denominator: 8349; Percentage: 73.1%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 3586; Denominator: 8349; Percentage: 43%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 4719; Denominator: 8349; Percentage: 56.5%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Negative" />
            <comment>
              <narrative>Numerator: 8267; Denominator: 8349; Percentage: 99%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Not documented" />
            <comment>
              <narrative>Numerator: 682; Denominator: 8349; Percentage: 8.2%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 82; Denominator: 8349; Percentage: 1%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-07-01" />
          <period-end iso-date="2019-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 9938.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 8603.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 10682.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 8337.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 6624; Denominator: 8258; Percentage: 80.2%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 1634; Denominator: 8258; Percentage: 19.8%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Type of TB" value="Bacteriologically confirmed" />
            <comment>
              <narrative>Numerator: 3898; Denominator: 8337; Percentage: 46.8%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 3509; Denominator: 8258; Percentage: 42.5%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 4749; Denominator: 8258; Percentage: 57.5%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Negative" />
            <comment>
              <narrative>Numerator: 8013; Denominator: 8082; Percentage: 99.2%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Not documented" />
            <comment>
              <narrative>Numerator: 255; Denominator: 8337; Percentage: 3.1%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 69; Denominator: 8082; Percentage: 0.8%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-07-01" />
          <period-end iso-date="2020-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 10682.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 8617.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 6876; Denominator: 8608; Percentage: 79.9%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 1732; Denominator: 8608; Percentage: 20.1%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Type of TB" value="Bacteriologically confirmed" />
            <comment>
              <narrative>Numerator: 4168; Denominator: 8617; Percentage: 48.4%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 3773; Denominator: 8608; Percentage: 43.8%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 4835; Denominator: 8608; Percentage: 56.2%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Negative" />
            <comment>
              <narrative>Numerator: 8122; Denominator: 8181; Percentage: 99.3%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Not documented" />
            <comment>
              <narrative>Numerator: 436; Denominator: 8617; Percentage: 5.1%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 59; Denominator: 8181; Percentage: 0.7%.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of laboratories showing adequate performance in external quality assurance for smear microscopy among the total number of laboratories that undertake smear microscopy during the reporting period</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of laboratories showing adequate performance in external quality assurance for smear microscopy among the total number of laboratories that undertake smear microscopy during the reporting period</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2016" iso-date="2016-12-31" value="75.34">
          <comment>
            <narrative>Numerator: 55; Denominator: 73.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-06-30" />
          <target value="74.7">
            <comment>
              <narrative>Numerator: 62; Denominator: 83.</narrative>
            </comment>
          </target>
          <actual value="97.4">
            <comment>
              <narrative>Numerator: 74; Denominator: 76.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-07-01" />
          <period-end iso-date="2018-12-31" />
          <target value="74.7">
            <comment>
              <narrative>Numerator: 62; Denominator: 83.</narrative>
            </comment>
          </target>
          <actual value="89.7">
            <comment>
              <narrative>Numerator: 70; Denominator: 78.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-06-30" />
          <target value="79.5">
            <comment>
              <narrative>Numerator: 58; Denominator: 73.</narrative>
            </comment>
          </target>
          <actual value="94.9">
            <comment>
              <narrative>Numerator: 74; Denominator: 78.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-07-01" />
          <period-end iso-date="2019-12-31" />
          <target value="79.45">
            <comment>
              <narrative>Numerator: 58; Denominator: 73.</narrative>
            </comment>
          </target>
          <actual value="94.5">
            <comment>
              <narrative>Numerator: 69; Denominator: 73.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-06-30" />
          <target value="100">
            <comment>
              <narrative>Numerator: 73; Denominator: 73.</narrative>
            </comment>
          </target>
          <actual value="100">
            <comment>
              <narrative>Numerator: 69; Denominator: 69.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-07-01" />
          <period-end iso-date="2020-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 73; Denominator: 73.</narrative>
            </comment>
          </target>
          <actual value="95.1">
            <comment>
              <narrative>Numerator: 78; Denominator: 82.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of reporting units reporting no stock-outs of anti-TB drugs on the last day of the quarter</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of reporting units reporting no stock-outs of anti-TB drugs on the last day of the quarter</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2016" iso-date="2016-12-31" value="68.49">
          <comment>
            <narrative>Numerator: 50; Denominator: 73.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-06-30" />
          <target value="80">
            <comment>
              <narrative>Numerator: 76; Denominator: 95.</narrative>
            </comment>
          </target>
          <actual value="72.5">
            <comment>
              <narrative>Numerator: 66; Denominator: 91.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-07-01" />
          <period-end iso-date="2018-12-31" />
          <target value="80">
            <comment>
              <narrative>Numerator: 76; Denominator: 95.</narrative>
            </comment>
          </target>
          <actual value="90.5">
            <comment>
              <narrative>Numerator: 86; Denominator: 95.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-06-30" />
          <target value="85.3">
            <comment>
              <narrative>Numerator: 81; Denominator: 95.</narrative>
            </comment>
          </target>
          <actual value="94.7">
            <comment>
              <narrative>Numerator: 89; Denominator: 94.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-07-01" />
          <period-end iso-date="2019-12-31" />
          <target value="85.26">
            <comment>
              <narrative>Numerator: 81; Denominator: 95.</narrative>
            </comment>
          </target>
          <actual value="93.7">
            <comment>
              <narrative>Numerator: 89; Denominator: 95.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-06-30" />
          <target value="90.53">
            <comment>
              <narrative>Numerator: 86; Denominator: 95.</narrative>
            </comment>
          </target>
          <actual value="98.9">
            <comment>
              <narrative>Numerator: 92; Denominator: 93.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-07-01" />
          <period-end iso-date="2020-12-31" />
          <target value="90.53">
            <comment>
              <narrative>Numerator: 86; Denominator: 95.</narrative>
            </comment>
          </target>
          <actual value="93.6">
            <comment>
              <narrative>Numerator: 88; Denominator: 94.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Treatment success rate- all forms: Percentage of TB cases, all forms, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB cases registered for treatment during a specified period, new and relapse cases</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Treatment success rate- all forms: Percentage of TB cases, all forms, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB cases registered for treatment during a specified period, new and relapse cases</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2016" iso-date="2016-12-31" value="86.46">
          <comment>
            <narrative>Numerator: 8837; Denominator: 10221.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-06-30" />
          <target value="90">
            <comment>
              <narrative>Numerator: 7965; Denominator: 8850.</narrative>
            </comment>
          </target>
          <actual value="87.8">
            <comment>
              <narrative>Numerator: 7150; Denominator: 8140.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-07-01" />
          <period-end iso-date="2018-12-31" />
          <target value="90">
            <comment>
              <narrative>Numerator: 7965; Denominator: 8850.</narrative>
            </comment>
          </target>
          <actual value="89.1">
            <comment>
              <narrative>Numerator: 7234; Denominator: 8122.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-06-30" />
          <target value="90">
            <comment>
              <narrative>Numerator: 8325; Denominator: 9250.</narrative>
            </comment>
          </target>
          <actual value="89.8">
            <comment>
              <narrative>Numerator: 7336; Denominator: 8173.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-07-01" />
          <period-end iso-date="2019-12-31" />
          <target value="90">
            <comment>
              <narrative>Numerator: 8325; Denominator: 9250.</narrative>
            </comment>
          </target>
          <actual value="89.4">
            <comment>
              <narrative>Numerator: 7256; Denominator: 8114.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-06-30" />
          <target value="90">
            <comment>
              <narrative>Numerator: 8685; Denominator: 9650.</narrative>
            </comment>
          </target>
          <actual value="90.1">
            <comment>
              <narrative>Numerator: 7848; Denominator: 8715.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-07-01" />
          <period-end iso-date="2020-12-31" />
          <target value="90">
            <comment>
              <narrative>Numerator: 8685; Denominator: 9650.</narrative>
            </comment>
          </target>
          <actual value="91.6">
            <comment>
              <narrative>Numerator: 7825; Denominator: 8544.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative>
      </title>
      <description>
        <narrative>Module: TB/HIV.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2016" iso-date="2016-12-31" value="59.2">
          <comment>
            <narrative>Numerator: 103; Denominator: 174.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-06-30" />
          <target value="75.3">
            <comment>
              <narrative>Numerator: 70; Denominator: 93.</narrative>
            </comment>
          </target>
          <actual value="55.6">
            <comment>
              <narrative>Numerator: 50; Denominator: 90.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-07-01" />
          <period-end iso-date="2018-12-31" />
          <target value="75.3">
            <comment>
              <narrative>Numerator: 70; Denominator: 93.</narrative>
            </comment>
          </target>
          <actual value="54.5">
            <comment>
              <narrative>Numerator: 42; Denominator: 77.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-06-30" />
          <target value="80">
            <comment>
              <narrative>Numerator: 76; Denominator: 95.</narrative>
            </comment>
          </target>
          <actual value="64.6">
            <comment>
              <narrative>Numerator: 53; Denominator: 82.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-07-01" />
          <period-end iso-date="2019-12-31" />
          <target value="80">
            <comment>
              <narrative>Numerator: 76; Denominator: 95.</narrative>
            </comment>
          </target>
          <actual value="80">
            <comment>
              <narrative>Numerator: 52; Denominator: 65.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-06-30" />
          <target value="85.13">
            <comment>
              <narrative>Numerator: 83; Denominator: 97.5.</narrative>
            </comment>
          </target>
          <actual value="84.1">
            <comment>
              <narrative>Numerator: 58; Denominator: 69.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-07-01" />
          <period-end iso-date="2020-12-31" />
          <target value="85.13">
            <comment>
              <narrative>Numerator: 83; Denominator: 97.5.</narrative>
            </comment>
          </target>
          <actual value="69.5">
            <comment>
              <narrative>Numerator: 41; Denominator: 59.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of registered new and relapse TB patients with documented HIV status</narrative>
      </title>
      <description>
        <narrative>Module: TB/HIV.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of registered new and relapse TB patients with documented HIV status</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2016" iso-date="2016-12-31" value="79.61">
          <comment>
            <narrative>Numerator: 11449; Denominator: 14381.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-06-30" />
          <target value="85">
            <comment>
              <narrative>Numerator: 7522.5; Denominator: 8850.</narrative>
            </comment>
          </target>
          <actual value="90.1">
            <comment>
              <narrative>Numerator: 7250; Denominator: 8046.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-07-01" />
          <period-end iso-date="2018-12-31" />
          <target value="85">
            <comment>
              <narrative>Numerator: 7523; Denominator: 8850.</narrative>
            </comment>
          </target>
          <actual value="95.3">
            <comment>
              <narrative>Numerator: 7689; Denominator: 8070.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-06-30" />
          <target value="90">
            <comment>
              <narrative>Numerator: 8325; Denominator: 9250.</narrative>
            </comment>
          </target>
          <actual value="91.8">
            <comment>
              <narrative>Numerator: 7667; Denominator: 8349.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-07-01" />
          <period-end iso-date="2019-12-31" />
          <target value="90">
            <comment>
              <narrative>Numerator: 8325; Denominator: 9250.</narrative>
            </comment>
          </target>
          <actual value="90.7">
            <comment>
              <narrative>Numerator: 7802; Denominator: 8603.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-06-30" />
          <target value="95.01">
            <comment>
              <narrative>Numerator: 9168; Denominator: 9650.</narrative>
            </comment>
          </target>
          <actual value="96.9">
            <comment>
              <narrative>Numerator: 8082; Denominator: 8337.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-07-01" />
          <period-end iso-date="2020-12-31" />
          <target value="95.01">
            <comment>
              <narrative>Numerator: 9168; Denominator: 9650.</narrative>
            </comment>
          </target>
          <actual value="94.9">
            <comment>
              <narrative>Numerator: 8181; Denominator: 8617.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
  </iati-activity>
  <iati-activity last-updated-datetime="2026-11-10T13:42:47+00:00" xml:lang="en" default-currency="USD" humanitarian="0" hierarchy="1">
    <iati-identifier>47045-SOM-T-WV-4</iati-identifier>
    <reporting-org ref="47045" type="30">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </reporting-org>
    <title>
      <narrative>Reducing TB incidence and TB related mortality among Somalis - Somalia (01-Jan-2021-31-Dec-2023)</narrative>
    </title>
    <description type="1">
      <narrative>Somalia, Tuberculosis, World Vision International</narrative>
    </description>
    <description type="2">
      <narrative>Goals: 50% reduction in TB deaths (compared with 2015); 30% reduction in TB incidence rate (compared with 2015); &gt;20% affected families facing catastrophic costs. Objectives: To increase case detection, and ensure treatment completion of all forms of notified drug susceptible TB cases from 16,918 in 2019 to 27,000 by 2023, while increasing the treatment success rate from 86% in 2017 to 90% by 2023; To increase the number of RR/MDR TB cases enrolled on treatment from 335 in 2019 to 1044 in 2023 while increasing the treatment success rate from 79% in the cohort of 2016 to &gt;85% in the cohort of 2021; To ensure all diagnosed TB patients are tested for HIV and are aware about their HIV status. In addition, increase the proportion of TB/HIV coinfected patients on ART to &gt; 90% by 2023 from existing 72% in 2019; NTP program management capacities improved at all levels (coordination, monitoring and evaluation, data collection and exploitation for planning, execution of operational research; The proportion of patients (children under five, HIV patients without TB disease, respectively) initiated on TPT increased to 80% in 2024.</narrative>
    </description>
    <participating-org ref="47045" type="30" role="1" crs-channel-code="47045">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </participating-org>
    <participating-org type="21" role="2" crs-channel-code="21000">
      <narrative>World Vision International</narrative>
    </participating-org>
    <participating-org type="21" role="4" crs-channel-code="21000">
      <narrative>World Vision International</narrative>
    </participating-org>
    <other-identifier ref="SOM-T-WVP04" type="A1">
      <owner-org ref="47045">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </owner-org>
    </other-identifier>
    <activity-status code="4" />
    <activity-date type="1" iso-date="2021-01-01" />
    <activity-date type="2" iso-date="2021-01-01" />
    <activity-date type="3" iso-date="2023-12-31" />
    <activity-date type="4" iso-date="2023-12-31" />
    <contact-info type="1">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Communications</narrative>
      </department>
      <telephone>+41 58 791 1700</telephone>
      <email>website@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <contact-info type="2">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Grant Management Division</narrative>
      </department>
      <person-name>
        <narrative>Amélie Joubert</narrative>
      </person-name>
      <job-title>
        <narrative>Fund Portfolio Manager</narrative>
      </job-title>
      <telephone>+41 58 791 1700</telephone>
      <email>amelie.joubert@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <activity-scope code="4" />
    <recipient-country code="SO" percentage="100">
      <narrative>Somalia</narrative>
    </recipient-country>
    <sector vocabulary="1" code="12263" percentage="68.8">
      <narrative>Tuberculosis</narrative>
    </sector>
    <sector vocabulary="1" code="12110" percentage="31.2">
      <narrative>Multicomponent, RSSH</narrative>
    </sector>
    <tag vocabulary="2" code="3">
      <narrative>Ensure healthy lives and promote well-being for all at all ages</narrative>
    </tag>
    <tag vocabulary="3" code="3.3">
      <narrative>End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases</narrative>
    </tag>
    <tag vocabulary="3" code="3.8">
      <narrative>Achieve universal health coverage</narrative>
    </tag>
    <country-budget-items vocabulary="4">
      <budget-item code="6a7cb452-4c5d-49b6-aa43-8437d24fa1c5" percentage="8.4">
        <description>
          <narrative>Multicomponent -&gt; Program management -&gt; Coordination and management of national disease control programs</narrative>
        </description>
      </budget-item>
      <budget-item code="31a8e187-9648-42f5-a520-92e7e53d4ac6" percentage="19.81">
        <description>
          <narrative>Multicomponent -&gt; Program management -&gt; Grant management</narrative>
        </description>
      </budget-item>
      <budget-item code="792f3049-9f2b-41ae-a2df-af58779797ea" percentage="0.25">
        <description>
          <narrative>RSSH -&gt; RSSH: Community systems strengthening -&gt; Community-led research and advocacy</narrative>
        </description>
      </budget-item>
      <budget-item code="e61e1ae8-85c6-488f-8a92-215981bf93a2" percentage="0.19">
        <description>
          <narrative>RSSH -&gt; RSSH: Community systems strengthening -&gt; Social mobilization, building community linkages and coordination</narrative>
        </description>
      </budget-item>
      <budget-item code="c9e8bc4a-398e-4c4b-afbb-cf98965f552e" percentage="0.18">
        <description>
          <narrative>RSSH -&gt; RSSH: Health management information systems and M&amp;E -&gt; Analysis, evaluations, reviews and transparency</narrative>
        </description>
      </budget-item>
      <budget-item code="d110361a-331b-4f72-bd32-016450445cc3" percentage="1.65">
        <description>
          <narrative>RSSH -&gt; RSSH: Health management information systems and M&amp;E -&gt; Program and data quality</narrative>
        </description>
      </budget-item>
      <budget-item code="b235c58e-3a80-49b8-aeb9-ddaad2b16768" percentage="0.19">
        <description>
          <narrative>RSSH -&gt; RSSH: Health management information systems and M&amp;E -&gt; Surveys</narrative>
        </description>
      </budget-item>
      <budget-item code="0fa82570-990a-4ca3-98f1-4952587f8be1" percentage="0.53">
        <description>
          <narrative>RSSH -&gt; RSSH: Integrated service delivery and quality improvement -&gt; Service delivery infrastructure</narrative>
        </description>
      </budget-item>
      <budget-item code="30f85a5d-1110-4276-932f-a742fc65c90f" percentage="5.91">
        <description>
          <narrative>Tuberculosis -&gt; MDR-TB -&gt; Case detection and diagnosis (MDR-TB)</narrative>
        </description>
      </budget-item>
      <budget-item code="452ec704-0b92-43c1-9cac-6649d925fde1" percentage="0.49">
        <description>
          <narrative>Tuberculosis -&gt; MDR-TB -&gt; Collaborative activities with other programs and sectors (MDR-TB)</narrative>
        </description>
      </budget-item>
      <budget-item code="9a89bb7c-0497-4574-b9d1-dd46b1823c81" percentage="0.36">
        <description>
          <narrative>Tuberculosis -&gt; MDR-TB -&gt; Engaging all care providers (MDR-TB)</narrative>
        </description>
      </budget-item>
      <budget-item code="0a397ad2-92e1-4673-8764-a74d9c839161" percentage="0.09">
        <description>
          <narrative>Tuberculosis -&gt; MDR-TB -&gt; Prevention (MDR-TB)</narrative>
        </description>
      </budget-item>
      <budget-item code="8194063f-1bf8-4be2-9ebd-2823d5ac44a3" percentage="8.16">
        <description>
          <narrative>Tuberculosis -&gt; MDR-TB -&gt; Treatment (MDR-TB)</narrative>
        </description>
      </budget-item>
      <budget-item code="75ab2142-781a-4a2a-b8e0-50e6a129924b" percentage="0.11">
        <description>
          <narrative>Tuberculosis -&gt; Removing human rights and gender related barriers to TB services -&gt; Community mobilization and advocacy (TB)</narrative>
        </description>
      </budget-item>
      <budget-item code="95aeb1ae-4531-4aec-8557-537759098b9c" percentage="0.3">
        <description>
          <narrative>Tuberculosis -&gt; Removing human rights and gender related barriers to TB services -&gt; Legal literacy ("Know Your Rights")</narrative>
        </description>
      </budget-item>
      <budget-item code="a93b0a8f-4b2d-4b43-806e-06b2f2240144" percentage="33.68">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Case detection and diagnosis (TB care and prevention)</narrative>
        </description>
      </budget-item>
      <budget-item code="e5d69248-af9e-44de-a99d-c2557c675f55" percentage="0.35">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Engaging all care providers (TB care and prevention)</narrative>
        </description>
      </budget-item>
      <budget-item code="a87c4f51-0287-43c7-9064-8f92833da8c6" percentage="1.3">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Key populations (TB care and prevention) - Mobile populations: refugees, migrants and internally displaced people</narrative>
        </description>
      </budget-item>
      <budget-item code="87435fc1-d92b-4039-b203-96061e6e85be" percentage="0.12">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Key populations (TB care and prevention) - Prisoners</narrative>
        </description>
      </budget-item>
      <budget-item code="3ec9daf3-963a-4853-8e5f-65867d3e7630" percentage="1.09">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Prevention (TB care and prevention)</narrative>
        </description>
      </budget-item>
      <budget-item code="2b47e4dd-6430-4bc5-829c-127bb93a72a8" percentage="16.04">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Treatment (TB care and prevention)</narrative>
        </description>
      </budget-item>
      <budget-item code="2146ce4f-9254-4a2a-8be8-e14734ab53dc" percentage="0.8">
        <description>
          <narrative>Tuberculosis -&gt; TB/HIV -&gt; TB/HIV - Collaborative interventions</narrative>
        </description>
      </budget-item>
    </country-budget-items>
    <collaboration-type code="1" />
    <default-flow-type code="10" />
    <default-finance-type code="110" />
    <default-aid-type code="C01" vocabulary="1" />
    <default-tied-status code="5" />
    <budget type="2" status="2">
      <period-start iso-date="2021-01-01" />
      <period-end iso-date="2021-12-31" />
      <value currency="USD" value-date="2021-01-01">7853467.04</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2022-01-01" />
      <period-end iso-date="2022-12-31" />
      <value currency="USD" value-date="2022-01-01">10939797.39</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2023-01-01" />
      <period-end iso-date="2023-12-31" />
      <value currency="USD" value-date="2023-01-01">12153872.13</value>
    </budget>
    <capital-spend percentage="4.45" />
    <transaction ref="673c5d3b-dbb4-4459-97da-1e8c6a141e40">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-01-07" />
      <value currency="USD" value-date="2021-01-07">15124909.72</value>
      <description>
        <narrative>Global Fund commitment to SOM-T-WVP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="fe2e6955-6a5d-41fe-88d9-65ab451f6049">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-01-13" />
      <value currency="USD" value-date="2021-01-13">3177945.38</value>
      <description>
        <narrative>Global Fund disbursement to SOM-T-WVP04 (International NGO).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="4fbbbde6-28a9-403c-a0f3-3ae1c0ea6142">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-01-29" />
      <value currency="USD" value-date="2021-01-29">324169.98</value>
      <description>
        <narrative>Global Fund disbursement to SOM-T-WVP04 (International NGO).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="01333efb-7694-45ba-920a-33f380dec977">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-02-19" />
      <value currency="USD" value-date="2021-02-19">387911.82</value>
      <description>
        <narrative>Global Fund disbursement to SOM-T-WVP04 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="751bf639-5deb-4217-99ea-2eef5f3b02cb">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-03-19" />
      <value currency="USD" value-date="2021-03-19">566119.33</value>
      <description>
        <narrative>Global Fund disbursement to SOM-T-WVP04 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="cfde7606-b072-4755-9696-62518c7b53d8">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-04-09" />
      <value currency="USD" value-date="2021-04-09">33853.95</value>
      <description>
        <narrative>Global Fund disbursement to SOM-T-WVP04 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="40bfe67b-cfcf-4b88-8a49-3d94e3d2eff6">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-07-07" />
      <value currency="USD" value-date="2021-07-07">50000.00</value>
      <description>
        <narrative>Global Fund commitment to SOM-T-WVP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="d8bd228e-7acb-4139-b407-ddd0d6b09952">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-07-29" />
      <value currency="USD" value-date="2021-07-29">1645881.73</value>
      <description>
        <narrative>Global Fund disbursement to SOM-T-WVP04 (International NGO).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="102640ec-9754-4cdd-804b-54f6b11dd922">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-08-26" />
      <value currency="USD" value-date="2021-08-26">254976.50</value>
      <description>
        <narrative>Global Fund disbursement to SOM-T-WVP04 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="abbfb9a2-956f-407c-bc3c-c5856f950712">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-10-28" />
      <value currency="USD" value-date="2021-10-28">3384087.00</value>
      <description>
        <narrative>Global Fund disbursement to SOM-T-WVP04 (International NGO).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="d8b18c9a-dfa1-4f11-abfc-b1edd6143c69">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-10-28" />
      <value currency="USD" value-date="2021-10-28">4065.97</value>
      <description>
        <narrative>Global Fund disbursement to SOM-T-WVP04 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="86019fd0-f702-4216-9558-b2ed3c2498da">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-11-18" />
      <value currency="USD" value-date="2021-11-18">24573.60</value>
      <description>
        <narrative>Global Fund disbursement to SOM-T-WVP04 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="b60b65c8-795d-49c1-af21-dcf9340e134b">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-11-18" />
      <value currency="USD" value-date="2021-11-18">218875.00</value>
      <description>
        <narrative>Global Fund disbursement to SOM-T-WVP04 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="35987bba-c418-4664-8542-b1900984576d">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-12-16" />
      <value currency="USD" value-date="2021-12-16">244779.50</value>
      <description>
        <narrative>Global Fund disbursement to SOM-T-WVP04 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="6d216c30-89ea-4f16-b033-83fe592a213b">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-12-16" />
      <value currency="USD" value-date="2021-12-16">532490.32</value>
      <description>
        <narrative>Global Fund disbursement to SOM-T-WVP04 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="1ed21d3e-1da8-4866-9aee-092b5636002e">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-01-20" />
      <value currency="USD" value-date="2022-01-20">95003.36</value>
      <description>
        <narrative>Global Fund disbursement to SOM-T-WVP04 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="887e9dff-9b53-4af5-b910-48517c0f898c">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-02-25" />
      <value currency="USD" value-date="2022-02-25">100000.00</value>
      <description>
        <narrative>Global Fund commitment to SOM-T-WVP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="a4f2419c-da13-4518-9b90-c31ccf3e5ac8">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-02-25" />
      <value currency="USD" value-date="2022-02-25">-50000.00</value>
      <description>
        <narrative>Global Fund commitment to SOM-T-WVP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="da1c36e9-18bd-4a98-a160-a9a9d7eac97a">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-03-14" />
      <value currency="USD" value-date="2022-03-14">50000.00</value>
      <description>
        <narrative>Global Fund disbursement to SOM-T-WVP04 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="ac18eaa4-977c-468e-88a7-55adb8169a49">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-04-21" />
      <value currency="USD" value-date="2022-04-21">22554.46</value>
      <description>
        <narrative>Global Fund disbursement to SOM-T-WVP04 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="e8705f88-86b9-4117-b4c2-2e90cf7058b9">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-05-24" />
      <value currency="USD" value-date="2022-05-24">3623465.00</value>
      <description>
        <narrative>Global Fund disbursement to SOM-T-WVP04 (International NGO).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="9b98a9ad-1ca4-43eb-93b0-2a4fdb17e619">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-06-09" />
      <value currency="USD" value-date="2022-06-09">23080.65</value>
      <description>
        <narrative>Global Fund disbursement to SOM-T-WVP04 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="fb2a801b-6409-46bf-a5be-6330d415a0d2">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-06-09" />
      <value currency="USD" value-date="2022-06-09">54225.16</value>
      <description>
        <narrative>Global Fund disbursement to SOM-T-WVP04 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="481a35c0-466d-441c-aab2-3592f9f52e5e">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-06-21" />
      <value currency="USD" value-date="2022-06-21">3359083.56</value>
      <description>
        <narrative>Global Fund commitment to SOM-T-WVP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="9689ba25-3843-423f-8f65-78bd47e56fbc">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-06-21" />
      <value currency="USD" value-date="2022-06-21">-506851.01</value>
      <description>
        <narrative>Global Fund commitment to SOM-T-WVP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="707ccdde-d045-4111-9e2b-9541cbcd64ab">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-06-23" />
      <value currency="USD" value-date="2022-06-23">1137510.72</value>
      <description>
        <narrative>Global Fund disbursement to SOM-T-WVP04 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="d686ccb2-9e06-4ce2-8a04-31cb349c19e0">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-06-23" />
      <value currency="USD" value-date="2022-06-23">225426.83</value>
      <description>
        <narrative>Global Fund disbursement to SOM-T-WVP04 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="2aed635c-f585-4be1-9e6a-8dbf0d80044d">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-09-22" />
      <value currency="USD" value-date="2022-09-22">788741.00</value>
      <description>
        <narrative>Global Fund disbursement to SOM-T-WVP04 (International NGO).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="3d3f3847-65b8-41fc-b7e9-028bdb1a8219">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-09-22" />
      <value currency="USD" value-date="2022-09-22">473838.83</value>
      <description>
        <narrative>Global Fund disbursement to SOM-T-WVP04 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="fec7ff62-cb1a-4d83-ae86-6165086edc31">
      <transaction-type code="7" />
      <transaction-date iso-date="2022-10-01" />
      <value currency="USD" value-date="2022-10-01">2326.28</value>
      <description>
        <narrative>Funds returned to the Global Fund from SOM-T-WVP04 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="21">
        <narrative>World Vision International</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="1a5ab513-ae5b-4d22-9683-056467ab6e67">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-10-13" />
      <value currency="USD" value-date="2022-10-13">9716899.00</value>
      <description>
        <narrative>Global Fund commitment to SOM-T-WVP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="753474b8-1265-412a-be88-a6746ac3ab37">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-10-13" />
      <value currency="USD" value-date="2022-10-13">-733566.18</value>
      <description>
        <narrative>Global Fund commitment to SOM-T-WVP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="9cb42db5-4611-4823-a30b-a496c129cd36">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-10-19" />
      <value currency="USD" value-date="2022-10-19">-2326.28</value>
      <description>
        <narrative>Global Fund commitment to SOM-T-WVP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="2e56fd46-f544-48ae-8fa3-59d66dbc90c0">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-10-20" />
      <value currency="USD" value-date="2022-10-20">44985.67</value>
      <description>
        <narrative>Global Fund disbursement to SOM-T-WVP04 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="7553b24b-2c98-4037-9a76-7ae74b65ab50">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-11-24" />
      <value currency="USD" value-date="2022-11-24">2091644.00</value>
      <description>
        <narrative>Global Fund disbursement to SOM-T-WVP04 (International NGO).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="a103f8b4-9d56-48a1-8410-af0c59d8dcfb">
      <transaction-type code="7" />
      <transaction-date iso-date="2022-12-01" />
      <value currency="USD" value-date="2022-12-01">9647.49</value>
      <description>
        <narrative>Funds returned to the Global Fund from SOM-T-WVP04 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="21">
        <narrative>World Vision International</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="5f8e1481-80c7-407d-82bf-46ae5e343f1f">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-12-15" />
      <value currency="USD" value-date="2022-12-15">-9647.49</value>
      <description>
        <narrative>Global Fund commitment to SOM-T-WVP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="c5d12767-cb19-420a-9df8-d52967a89ff0">
      <transaction-type code="7" />
      <transaction-date iso-date="2023-01-01" />
      <value currency="USD" value-date="2023-01-01">600.00</value>
      <description>
        <narrative>Funds returned to the Global Fund from SOM-T-WVP04 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="21">
        <narrative>World Vision International</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="b54dd5cf-4b93-4d5c-bae2-7604563f37fb">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-01-19" />
      <value currency="USD" value-date="2023-01-19">-600.00</value>
      <description>
        <narrative>Global Fund commitment to SOM-T-WVP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="80e4abba-9549-45c7-bf47-7b011eb54b1e">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-02-07" />
      <value currency="USD" value-date="2023-02-07">642488.93</value>
      <description>
        <narrative>Global Fund disbursement to SOM-T-WVP04 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="3f9f4087-4229-4bf8-8bac-9675b2d4e82c">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-02-16" />
      <value currency="USD" value-date="2023-02-16">2468265.00</value>
      <description>
        <narrative>Global Fund disbursement to SOM-T-WVP04 (International NGO).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="7842a9d1-cc50-4ee2-b941-b6a1f89b89c3">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-02-16" />
      <value currency="USD" value-date="2023-02-16">288576.33</value>
      <description>
        <narrative>Global Fund disbursement to SOM-T-WVP04 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="e84a8d90-07cc-40bb-92d4-8d71efa5f017">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-03-21" />
      <value currency="USD" value-date="2023-03-21">50000.00</value>
      <description>
        <narrative>Global Fund disbursement to SOM-T-WVP04 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="8313dd47-83ea-46c0-b721-b37a1b86eb2d">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-04-04" />
      <value currency="USD" value-date="2023-04-04">127184.01</value>
      <description>
        <narrative>Global Fund disbursement to SOM-T-WVP04 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="fffe0e33-0338-4eca-b0d2-a9a1489bdb50">
      <transaction-type code="7" />
      <transaction-date iso-date="2023-04-12" />
      <value currency="USD" value-date="2023-04-12">6656.78</value>
      <description>
        <narrative>Funds returned to the Global Fund from SOM-T-WVP04 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="21">
        <narrative>World Vision International</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="6d50b121-485f-4b0e-bc65-3680675f020c">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-04-26" />
      <value currency="USD" value-date="2023-04-26">-6656.78</value>
      <description>
        <narrative>Global Fund commitment to SOM-T-WVP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="22d74d70-0bb9-4db7-ac4e-a0be32093c5e">
      <transaction-type code="7" />
      <transaction-date iso-date="2023-05-01" />
      <value currency="USD" value-date="2023-05-01">15467.49</value>
      <description>
        <narrative>Funds returned to the Global Fund from SOM-T-WVP04 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="21">
        <narrative>World Vision International</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="66b9c955-062e-4c5e-84b9-1220776a9d53">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-05-04" />
      <value currency="USD" value-date="2023-05-04">-15467.49</value>
      <description>
        <narrative>Global Fund commitment to SOM-T-WVP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="62bbd013-db6c-45c9-9aa1-50855588e5c6">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-05-31" />
      <value currency="USD" value-date="2023-05-31">3041568.00</value>
      <description>
        <narrative>Global Fund commitment to SOM-T-WVP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="b1811f3e-ea05-4211-a43a-ae679afb7609">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-05-31" />
      <value currency="USD" value-date="2023-05-31">-4053755.06</value>
      <description>
        <narrative>Global Fund commitment to SOM-T-WVP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="2bd1f5a4-b783-4bc5-86e8-cefced5d8d73">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-06-06" />
      <value currency="USD" value-date="2023-06-06">8947.56</value>
      <description>
        <narrative>Global Fund disbursement to SOM-T-WVP04 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="a390b127-4382-4fb0-b59d-469c886d5fb7">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-06-20" />
      <value currency="USD" value-date="2023-06-20">37394.02</value>
      <description>
        <narrative>Global Fund disbursement to SOM-T-WVP04 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="9f4af27e-7972-4c07-beaa-36a75b6d0cc7">
      <transaction-type code="7" />
      <transaction-date iso-date="2023-07-01" />
      <value currency="USD" value-date="2023-07-01">2281.97</value>
      <description>
        <narrative>Funds returned to the Global Fund from SOM-T-WVP04 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="21">
        <narrative>World Vision International</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="a0cb215e-7bd1-4c75-8f1e-44b15a234164">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-07-04" />
      <value currency="USD" value-date="2023-07-04">2995226.42</value>
      <description>
        <narrative>Global Fund disbursement to SOM-T-WVP04 (International NGO).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="77e6f817-1d34-4469-9ecb-ab182a494822">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-07-12" />
      <value currency="USD" value-date="2023-07-12">4933546.00</value>
      <description>
        <narrative>Global Fund commitment to SOM-T-WVP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="1c487276-1b39-4e87-9501-42b491f12df7">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-07-12" />
      <value currency="USD" value-date="2023-07-12">-2281.97</value>
      <description>
        <narrative>Global Fund commitment to SOM-T-WVP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="47a3d679-c07a-4472-b63f-e2e78d631728">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-07-18" />
      <value currency="USD" value-date="2023-07-18">684332.00</value>
      <description>
        <narrative>Global Fund disbursement to SOM-T-WVP04 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="cb95ee16-b873-4e82-a7bc-d81afa43e4ca">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-07-23" />
      <value currency="USD" value-date="2023-07-23">50000.00</value>
      <description>
        <narrative>Global Fund commitment to SOM-T-WVP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="e6d597c4-fe15-4065-8277-44c2c62ff97d">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-08-28" />
      <value currency="USD" value-date="2023-08-28">-299.98</value>
      <description>
        <narrative>Global Fund commitment to SOM-T-WVP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="0561e800-05fb-4f3e-bb0e-98ec10fc7155">
      <transaction-type code="7" />
      <transaction-date iso-date="2023-09-01" />
      <value currency="USD" value-date="2023-09-01">299.98</value>
      <description>
        <narrative>Funds returned to the Global Fund from SOM-T-WVP04 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="21">
        <narrative>World Vision International</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="9ddca942-bed6-43f1-83b0-69e9fb985624">
      <transaction-type code="7" />
      <transaction-date iso-date="2023-09-08" />
      <value currency="USD" value-date="2023-09-08">12362.75</value>
      <description>
        <narrative>Funds returned to the Global Fund from SOM-T-WVP04 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="21">
        <narrative>World Vision International</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="bae6e6ec-3d8f-4ab3-b710-9e1b3ed51113">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-09-14" />
      <value currency="USD" value-date="2023-09-14">-4249214.00</value>
      <description>
        <narrative>Global Fund commitment to SOM-T-WVP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="e0ea8bbd-ab21-49a8-9d7e-3a8695f7e1a8">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-09-14" />
      <value currency="USD" value-date="2023-09-14">4199214.00</value>
      <description>
        <narrative>Global Fund commitment to SOM-T-WVP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="57f08fad-217d-4f0f-96a4-00102c6b0568">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-09-19" />
      <value currency="USD" value-date="2023-09-19">89948.45</value>
      <description>
        <narrative>Global Fund disbursement to SOM-T-WVP04 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="57b1cc41-9cdd-4955-8d21-31e3215c752f">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-09-20" />
      <value currency="USD" value-date="2023-09-20">-12362.75</value>
      <description>
        <narrative>Global Fund commitment to SOM-T-WVP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="a8052b35-f38d-4057-8c58-e5c8d62e48aa">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-09-28" />
      <value currency="USD" value-date="2023-09-28">2677890.00</value>
      <description>
        <narrative>Global Fund disbursement to SOM-T-WVP04 (International NGO).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="508c0153-5f66-4985-93b4-9cc2c5e22369">
      <transaction-type code="7" />
      <transaction-date iso-date="2023-12-01" />
      <value currency="USD" value-date="2023-12-01">107607.56</value>
      <description>
        <narrative>Funds returned to the Global Fund from SOM-T-WVP04 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="21">
        <narrative>World Vision International</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="0894bd5c-3781-43c6-ba37-c2b8e5fbc208">
      <transaction-type code="7" />
      <transaction-date iso-date="2023-12-04" />
      <value currency="USD" value-date="2023-12-04">1666.85</value>
      <description>
        <narrative>Funds returned to the Global Fund from SOM-T-WVP04 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="21">
        <narrative>World Vision International</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="6ea02eb4-bbe0-405b-857b-2b600e3a0fba">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-12-05" />
      <value currency="USD" value-date="2023-12-05">1422348.00</value>
      <description>
        <narrative>Global Fund disbursement to SOM-T-WVP04 (International NGO).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="a2a5cbd3-1c1e-4788-b393-05ab60368694">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-12-22" />
      <value currency="USD" value-date="2023-12-22">-107607.56</value>
      <description>
        <narrative>Global Fund commitment to SOM-T-WVP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="c737fa08-2c96-4533-bfe2-3b5e7fce0fc5">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-12-22" />
      <value currency="USD" value-date="2023-12-22">-1666.85</value>
      <description>
        <narrative>Global Fund commitment to SOM-T-WVP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="d5a71665-bb7a-4362-9218-f8da76405e33">
      <transaction-type code="7" />
      <transaction-date iso-date="2024-04-12" />
      <value currency="USD" value-date="2024-04-12">103.00</value>
      <description>
        <narrative>Funds returned to the Global Fund from SOM-T-WVP04 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="21">
        <narrative>World Vision International</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="b2d264d1-b905-476e-a445-d39fc9dc0770">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-04-26" />
      <value currency="USD" value-date="2024-04-26">-103.00</value>
      <description>
        <narrative>Global Fund commitment to SOM-T-WVP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="c1ed86cd-2b03-4374-b8d3-434d7eeffae6">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-05-16" />
      <value currency="USD" value-date="2024-05-16">-50000.00</value>
      <description>
        <narrative>Global Fund commitment to SOM-T-WVP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="5c7e7dbd-828e-4898-aeb0-a5133faf6cb5">
      <transaction-type code="7" />
      <transaction-date iso-date="2024-07-01" />
      <value currency="USD" value-date="2024-07-01">6604.49</value>
      <description>
        <narrative>Funds returned to the Global Fund from SOM-T-WVP04 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="21">
        <narrative>World Vision International</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="be2f493b-ccb3-4275-a25d-eac0643933c4">
      <transaction-type code="7" />
      <transaction-date iso-date="2024-07-01" />
      <value currency="USD" value-date="2024-07-01">1539.15</value>
      <description>
        <narrative>Funds returned to the Global Fund from SOM-T-WVP04 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="21">
        <narrative>World Vision International</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="79c6f9aa-5b28-4701-b479-0faed5eb9af8">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-07-03" />
      <value currency="USD" value-date="2024-07-03">-6604.49</value>
      <description>
        <narrative>Global Fund commitment to SOM-T-WVP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="0f183c59-9941-41f0-b4e0-96adf5100977">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-07-05" />
      <value currency="USD" value-date="2024-07-05">-1539.15</value>
      <description>
        <narrative>Global Fund commitment to SOM-T-WVP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="2f6d18a2-19d0-4c7b-b694-ea3785f170e0">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-09-30" />
      <value currency="USD" value-date="2024-09-30">-26460.16</value>
      <description>
        <narrative>Global Fund commitment to SOM-T-WVP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="13189e54-034a-41fd-abfe-31e7805f536c">
      <transaction-type code="7" />
      <transaction-date iso-date="2024-10-01" />
      <value currency="USD" value-date="2024-10-01">26460.16</value>
      <description>
        <narrative>Funds returned to the Global Fund from SOM-T-WVP04 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="21">
        <narrative>World Vision International</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="56fa4906-d58f-430e-a7f1-56872a289358">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-05-23" />
      <value currency="USD" value-date="2025-05-23">-9027.55</value>
      <description>
        <narrative>Global Fund commitment to SOM-T-WVP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="8d2b63c6-25d9-4f93-b7ab-862010da2193">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-05-23" />
      <value currency="USD" value-date="2025-05-23">205258.55</value>
      <description>
        <narrative>Global Fund commitment to SOM-T-WVP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="9c78aad2-7055-45c8-a576-b56e8f25b4cb">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-06-11" />
      <value currency="USD" value-date="2025-06-11">205258.55</value>
      <description>
        <narrative>Global Fund disbursement to SOM-T-WVP04 (International NGO).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="SOM-T-WVP04-EXP-20211231">
      <transaction-type code="4" />
      <transaction-date iso-date="2021-12-31" />
      <value currency="USD" value-date="2021-12-31">7853467.30</value>
      <description>
        <narrative>Expenditure reported by World Vision International for SOM-T-WVP04, Jan 2021 to Dec 2021.</narrative>
      </description>
      <provider-org type="21">
        <narrative>World Vision International</narrative>
      </provider-org>
    </transaction>
    <transaction ref="SOM-T-WVP04-EXP-20221231">
      <transaction-type code="4" />
      <transaction-date iso-date="2022-12-31" />
      <value currency="USD" value-date="2022-12-31">10037220.15</value>
      <description>
        <narrative>Expenditure reported by World Vision International for SOM-T-WVP04, Jan 2022 to Dec 2022.</narrative>
      </description>
      <provider-org type="21">
        <narrative>World Vision International</narrative>
      </provider-org>
    </transaction>
    <transaction ref="SOM-T-WVP04-EXP-20231231">
      <transaction-type code="4" />
      <transaction-date iso-date="2023-12-31" />
      <value currency="USD" value-date="2023-12-31">13055360.98</value>
      <description>
        <narrative>Expenditure reported by World Vision International for SOM-T-WVP04, Jan 2023 to Dec 2023.</narrative>
      </description>
      <provider-org type="21">
        <narrative>World Vision International</narrative>
      </provider-org>
    </transaction>
    <transaction ref="SOM-T-WVP04-EXP-20240630">
      <transaction-type code="4" />
      <transaction-date iso-date="2024-06-30" />
      <value currency="USD" value-date="2024-06-30">-27570.16</value>
      <description>
        <narrative>Expenditure reported by World Vision International for SOM-T-WVP04, Jan 2024 to Jun 2024.</narrative>
      </description>
      <provider-org type="21">
        <narrative>World Vision International</narrative>
      </provider-org>
    </transaction>
    <document-link url="https://data.theglobalfund.org/grant/SOM-T-WV" format="text/html">
      <title>
        <narrative>Grant page on the data explorer of the Global Fund.</narrative>
      </title>
      <description>
        <narrative>An overview of a grant over its lifetime.</narrative>
      </description>
      <category code="A12" />
      <category code="A01" />
      <category code="A02" />
      <category code="A05" />
      <category code="A07" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2026-11-11" />
    </document-link>
    <document-link url="https://www.theglobalfund.org/media/13342/core_grantregulationsversiontwo_regulations_en.pdf" format="application/pdf">
      <title>
        <narrative>Grant terms and conditions.</narrative>
      </title>
      <description>
        <narrative>General terms and conditions which apply to Global Fund grants.</narrative>
      </description>
      <category code="A04" />
      <language code="en" />
    </document-link>
    <document-link url="https://docs.theglobalfund.org/files/Applications/Funding Requests/SOM/2020/Tuberculosis/en/SOM-T_FundingRequest_1_en.zip" format="application/zip">
      <title>
        <narrative>2020 - Funding Request - Window 2c - Tuberculosis - Somalia - English</narrative>
      </title>
      <description>
        <narrative>Funding Request of funding request FR723-SOM-T.</narrative>
      </description>
      <category code="A01" />
      <category code="A02" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2020-06-30" />
    </document-link>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of TB cases with RR-TB and/or MDR-TB notified</narrative>
      </title>
      <description>
        <narrative>Module: MDR-TB.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of TB cases with RR-TB and/or MDR-TB notified</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31">
          <comment>
            <narrative>Numerator: 336.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 307.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 307.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 29.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 29.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 222.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 222.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 114.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 114.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 324.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 171.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 648.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 357.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 324.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 186.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 846.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 345.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 423.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 182.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 423.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 163.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 522.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 153.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 132; Denominator: 153; Percentage: 86.27%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 21; Denominator: 153; Percentage: 13.73%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 42; Denominator: 153; Percentage: 27.45%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 111; Denominator: 153; Percentage: 72.55%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 1044.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 323.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2023-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 522.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 170.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 156; Denominator: 170; Percentage: 91.76%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 14; Denominator: 170; Percentage: 8.24%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 46; Denominator: 170; Percentage: 27.06%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 124; Denominator: 170; Percentage: 72.94%.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative>
      </title>
      <description>
        <narrative>Module: MDR-TB.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31">
          <comment>
            <narrative>Numerator: 336.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 307.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 307.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 29.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 29.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 222.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 222.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 114.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 114.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="TB regimen" value="Short regimens" />
          <comment>
            <narrative>Numerator: 199.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="TB regimen" value="Short regimens" />
          <comment>
            <narrative>Numerator: 199.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 324.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 131.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 648.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 299.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 324.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 168.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 423.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 162.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 846.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 310.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 423.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 148.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 522.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 144.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 126; Denominator: 144; Percentage: 87.5%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 18; Denominator: 144; Percentage: 12.5%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 42; Denominator: 144; Percentage: 29.17%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 102; Denominator: 144; Percentage: 70.83%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="TB regimen" value="Short regimens" />
            <comment>
              <narrative>Numerator: 144; Denominator: 144; Percentage: 100%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 1044.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 311.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2023-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 522.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 167.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 147; Denominator: 167; Percentage: 88.02%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 20; Denominator: 167; Percentage: 11.98%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 57; Denominator: 167; Percentage: 34.13%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 110; Denominator: 167; Percentage: 65.87%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="TB regimen" value="Short regimens" />
            <comment>
              <narrative>Numerator: 161; Denominator: 167; Percentage: 96.41%.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Treatment success rate of RR TB and/or MDR-TB: Percentage of cases with RR and/or MDR-TB successfully treated</narrative>
      </title>
      <description>
        <narrative>Module: MDR-TB.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Treatment success rate of RR TB and/or MDR-TB: Percentage of cases with RR and/or MDR-TB successfully treated</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31">
          <comment>
            <narrative>Numerator: 249; Denominator: 315; Percentage: 79.05%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Type of TB" value="XDR TB" />
          <comment>
            <narrative>Numerator: 3; Denominator: 3; Percentage: 100%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target>
            <comment>
              <narrative>Percentage: 79%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 117; Denominator: 173; Percentage: 67.6%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target>
            <comment>
              <narrative>Percentage: 79%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 117; Denominator: 173; Percentage: 67.6%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target>
            <comment>
              <narrative>Percentage: 80%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 106; Denominator: 127; Percentage: 83.5%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <target>
            <comment>
              <narrative>Percentage: 80%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 106; Denominator: 127; Percentage: 83.5%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target>
            <comment>
              <narrative>Percentage: 85%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 135; Denominator: 148; Percentage: 91.2%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2023-12-31" />
          <target>
            <comment>
              <narrative>Percentage: 85%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 135; Denominator: 148; Percentage: 91.2%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Type of TB" value="XDR TB" />
            <comment>
              <narrative>Numerator: 0; Denominator: 0.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Timeliness of facility reporting: Percentage of submitted facility monthly reports (for the reporting period) that are received on time per the national guidelines</narrative>
      </title>
      <description>
        <narrative>Module: RSSH: Health management information systems and M&amp;E.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Timeliness of facility reporting: Percentage of submitted facility monthly reports (for the reporting period) that are received on time per the national guidelines</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31" value="85.26">
          <comment>
            <narrative>Numerator: 81; Denominator: 95.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target value="88">
            <comment>
              <narrative>Numerator: 88; Denominator: 100.</narrative>
            </comment>
          </target>
          <actual value="90.7">
            <comment>
              <narrative>Numerator: 88; Denominator: 97.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target value="88">
            <comment>
              <narrative>Numerator: 176; Denominator: 200.</narrative>
            </comment>
          </target>
          <actual value="94.4">
            <comment>
              <narrative>Numerator: 184; Denominator: 195.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target value="88">
            <comment>
              <narrative>Numerator: 88; Denominator: 100.</narrative>
            </comment>
          </target>
          <actual value="98">
            <comment>
              <narrative>Numerator: 96; Denominator: 98.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target value="90">
            <comment>
              <narrative>Numerator: 94.5; Denominator: 105.</narrative>
            </comment>
          </target>
          <actual value="100">
            <comment>
              <narrative>Numerator: 97; Denominator: 97.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target value="90">
            <comment>
              <narrative>Numerator: 189; Denominator: 210.</narrative>
            </comment>
          </target>
          <actual value="99.3">
            <comment>
              <narrative>Numerator: 301; Denominator: 303.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <target value="90">
            <comment>
              <narrative>Numerator: 94.5; Denominator: 105.</narrative>
            </comment>
          </target>
          <actual value="99">
            <comment>
              <narrative>Numerator: 204; Denominator: 206.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target value="90">
            <comment>
              <narrative>Numerator: 198; Denominator: 220.</narrative>
            </comment>
          </target>
          <actual value="100">
            <comment>
              <narrative>Numerator: 414; Denominator: 414.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target value="90">
            <comment>
              <narrative>Numerator: 99; Denominator: 110.</narrative>
            </comment>
          </target>
          <actual value="100">
            <comment>
              <narrative>Numerator: 190; Denominator: 190.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2023-12-31" />
          <target value="90">
            <comment>
              <narrative>Numerator: 99; Denominator: 110.</narrative>
            </comment>
          </target>
          <actual value="100">
            <comment>
              <narrative>Numerator: 224; Denominator: 224.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of notified TB cases (all forms) contributed by non-national TB program providers - private/non-governmental facilities</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of notified TB cases (all forms) contributed by non-national TB program providers - private/non-governmental facilities</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31" value="2427" />
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target value="2160" />
          <actual value="1158" />
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target value="4320" />
          <actual value="2494" />
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target value="2160" />
          <actual value="1336" />
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target value="3037.5" />
          <actual value="1419" />
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target value="6075" />
          <actual value="2851" />
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <target value="3037.5" />
          <actual value="1432" />
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target value="8100" />
          <actual value="2962" />
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target value="4050" />
          <actual value="1436" />
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2023-12-31" />
          <target value="4050" />
          <actual value="1526" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31">
          <comment>
            <narrative>Numerator: 16918.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 12437.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 12437.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 3577.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 3577.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Type of TB" value="Bacteriologically confirmed" />
          <comment>
            <narrative>Numerator: 7857.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Type of TB" value="Bacteriologically confirmed" />
          <comment>
            <narrative>Numerator: 7857.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 6642.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 6642.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 9372.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 9372.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Negative" />
          <comment>
            <narrative>Numerator: 15322.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Negative" />
          <comment>
            <narrative>Numerator: 15322.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Not documented" />
          <comment>
            <narrative>Numerator: 1483.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Not documented" />
          <comment>
            <narrative>Numerator: 1483.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 147.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 147.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 10800.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 8303.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 21600.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 17201.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 10800.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 8898.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 24300.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 18255.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 12150.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 9083.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 12150.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 9172.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 13500.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 9102.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 7311; Denominator: 9102; Percentage: 80.32%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 1791; Denominator: 9102; Percentage: 19.68%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Type of TB" value="Bacteriologically confirmed" />
            <comment>
              <narrative>Numerator: 4373; Denominator: 9102; Percentage: 48.04%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 3996; Denominator: 9102; Percentage: 43.9%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 5106; Denominator: 9102; Percentage: 56.1%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Negative" />
            <comment>
              <narrative>Numerator: 8605; Denominator: 9102; Percentage: 94.54%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Not documented" />
            <comment>
              <narrative>Numerator: 443; Denominator: 9102; Percentage: 4.87%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 54; Denominator: 9102; Percentage: 0.59%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 27000.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 18384.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2023-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 13500.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 9282.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 7612; Denominator: 9282; Percentage: 82.01%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 1670; Denominator: 9282; Percentage: 17.99%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Type of TB" value="Bacteriologically confirmed" />
            <comment>
              <narrative>Numerator: 4519; Denominator: 9282; Percentage: 48.69%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 3920; Denominator: 9282; Percentage: 42.23%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 5362; Denominator: 9282; Percentage: 57.77%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Negative" />
            <comment>
              <narrative>Numerator: 8631; Denominator: 9282; Percentage: 92.99%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Not documented" />
            <comment>
              <narrative>Numerator: 604; Denominator: 9282; Percentage: 6.51%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 47; Denominator: 9282; Percentage: 0.51%.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of laboratories showing adequate performance in external quality assurance for smear microscopy among the total number of laboratories that undertake smear microscopy during the reporting period</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of laboratories showing adequate performance in external quality assurance for smear microscopy among the total number of laboratories that undertake smear microscopy during the reporting period</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative - other.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31" value="85.26">
          <comment>
            <narrative>Numerator: 81; Denominator: 95.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target value="90">
            <comment>
              <narrative>Numerator: 90; Denominator: 100.</narrative>
            </comment>
          </target>
          <actual value="92.2">
            <comment>
              <narrative>Numerator: 83; Denominator: 90.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target value="90">
            <comment>
              <narrative>Numerator: 90; Denominator: 100.</narrative>
            </comment>
          </target>
          <actual value="92.6">
            <comment>
              <narrative>Numerator: 25; Denominator: 27.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target value="90">
            <comment>
              <narrative>Numerator: 90; Denominator: 100.</narrative>
            </comment>
          </target>
          <actual value="92.2">
            <comment>
              <narrative>Numerator: 83; Denominator: 90.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target value="90.5">
            <comment>
              <narrative>Numerator: 95; Denominator: 105.</narrative>
            </comment>
          </target>
          <actual value="85.7">
            <comment>
              <narrative>Numerator: 90; Denominator: 105.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target value="90.48">
            <comment>
              <narrative>Numerator: 95; Denominator: 105.</narrative>
            </comment>
          </target>
          <actual value="95.5">
            <comment>
              <narrative>Numerator: 84; Denominator: 88.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <target value="90.48">
            <comment>
              <narrative>Numerator: 95; Denominator: 105.</narrative>
            </comment>
          </target>
          <actual value="85.7">
            <comment>
              <narrative>Numerator: 90; Denominator: 105.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target value="90">
            <comment>
              <narrative>Numerator: 99; Denominator: 110.</narrative>
            </comment>
          </target>
          <actual value="83.6">
            <comment>
              <narrative>Numerator: 92; Denominator: 110.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target value="90">
            <comment>
              <narrative>Numerator: 99; Denominator: 110.</narrative>
            </comment>
          </target>
          <actual value="83.6">
            <comment>
              <narrative>Numerator: 92; Denominator: 110.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2023-12-31" />
          <target value="90">
            <comment>
              <narrative>Numerator: 99; Denominator: 110.</narrative>
            </comment>
          </target>
          <actual value="83.6">
            <comment>
              <narrative>Numerator: 92; Denominator: 110.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of new and relapse TB patients tested using WHO recommended rapid tests at the time of diagnosis</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of new and relapse TB patients tested using WHO recommended rapid tests at the time of diagnosis</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31" value="24" />
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target value="35" />
          <actual value="27.9" />
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target value="35" />
          <actual value="32.6">
            <comment>
              <narrative>Numerator: 2899; Denominator: 8898.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target value="35" />
          <actual value="32.6">
            <comment>
              <narrative>Numerator: 2899; Denominator: 8898.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target value="50" />
          <actual value="36.2">
            <comment>
              <narrative>Numerator: 6609; Denominator: 18255.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target value="50" />
          <actual value="34">
            <comment>
              <narrative>Numerator: 3089; Denominator: 9083.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <target value="50" />
          <actual value="38.4">
            <comment>
              <narrative>Numerator: 3520; Denominator: 9172.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target value="65" />
          <actual value="40.3">
            <comment>
              <narrative>Numerator: 3672; Denominator: 9102.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target value="65" />
          <actual value="56.8">
            <comment>
              <narrative>Numerator: 10435; Denominator: 18384.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2023-12-31" />
          <target value="65" />
          <actual value="72.9">
            <comment>
              <narrative>Numerator: 6763; Denominator: 9282.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Treatment success rate- all forms: Percentage of TB cases, all forms, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB cases registered for treatment during a specified period, new and relapse cases</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Treatment success rate- all forms: Percentage of TB cases, all forms, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB cases registered for treatment during a specified period, new and relapse cases</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31" value="85.77">
          <comment>
            <narrative>Numerator: 14300; Denominator: 16673.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target value="90" />
          <actual value="92.6" />
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target value="90" />
          <actual value="94.8">
            <comment>
              <narrative>Numerator: 7555; Denominator: 7968.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target value="90" />
          <actual value="94.8">
            <comment>
              <narrative>Numerator: 7555; Denominator: 7968.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target value="90" />
          <actual value="93.4">
            <comment>
              <narrative>Numerator: 15833; Denominator: 16946.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target value="90" />
          <actual value="92.4">
            <comment>
              <narrative>Numerator: 7495; Denominator: 8112.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <target value="90" />
          <actual value="94.4">
            <comment>
              <narrative>Numerator: 8338; Denominator: 8834.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target value="90" />
          <actual value="92.7">
            <comment>
              <narrative>Numerator: 8423; Denominator: 9083.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target value="90" />
          <actual value="91.7">
            <comment>
              <narrative>Numerator: 16734; Denominator: 18255.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2023-12-31" />
          <target value="90" />
          <actual value="90.6">
            <comment>
              <narrative>Numerator: 8311; Denominator: 9172.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative>
      </title>
      <description>
        <narrative>Module: TB/HIV.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31" value="79.71">
          <comment>
            <narrative>Numerator: 110; Denominator: 138.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target value="80" />
          <actual value="63.5" />
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target value="81.4" />
          <actual value="76.7">
            <comment>
              <narrative>Numerator: 46; Denominator: 60.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target value="81.43" />
          <actual value="76.7">
            <comment>
              <narrative>Numerator: 46; Denominator: 60.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target value="83.6" />
          <actual value="80.2">
            <comment>
              <narrative>Numerator: 101; Denominator: 126.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target value="83.33" />
          <actual value="71.9">
            <comment>
              <narrative>Numerator: 46; Denominator: 64.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <target value="83.56" />
          <actual value="88.7">
            <comment>
              <narrative>Numerator: 55; Denominator: 62.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target value="86.5" />
          <actual value="79.2">
            <comment>
              <narrative>Numerator: 80; Denominator: 101.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target value="85.14" />
          <actual value="88.9">
            <comment>
              <narrative>Numerator: 48; Denominator: 54.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2023-12-31" />
          <target value="86.49" />
          <actual value="68.1">
            <comment>
              <narrative>Numerator: 32; Denominator: 47.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of PLHIV on ART who initiated TB preventive therapy among those eligible during the reporting period</narrative>
      </title>
      <description>
        <narrative>Module: TB/HIV.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of PLHIV on ART who initiated TB preventive therapy among those eligible during the reporting period</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31" value="23.22">
          <comment>
            <narrative>Numerator: 134; Denominator: 577.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target value="67" />
          <actual value="65.7">
            <comment>
              <narrative>Numerator: 163; Denominator: 248.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target value="64.8" />
          <actual value="65.9" />
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target value="67" />
          <actual value="65.7">
            <comment>
              <narrative>Numerator: 163; Denominator: 248.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target value="77.1" />
          <actual value="62.2">
            <comment>
              <narrative>Numerator: 329; Denominator: 529.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target value="73.9" />
          <actual value="62.7">
            <comment>
              <narrative>Numerator: 163; Denominator: 260.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <target value="77.1" />
          <actual value="61.7">
            <comment>
              <narrative>Numerator: 166; Denominator: 269.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target value="80" />
          <actual value="53.4">
            <comment>
              <narrative>Numerator: 141; Denominator: 264.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target value="80" />
          <actual value="65.6">
            <comment>
              <narrative>Numerator: 351; Denominator: 535.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2023-12-31" />
          <target value="80" />
          <actual value="77.5">
            <comment>
              <narrative>Numerator: 210; Denominator: 271.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
  </iati-activity>
  <iati-activity last-updated-datetime="2026-11-11T13:38:06+00:00" xml:lang="en" default-currency="USD" humanitarian="0" hierarchy="1">
    <iati-identifier>47045-SOM-T-WV-5</iati-identifier>
    <reporting-org ref="47045" type="30">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </reporting-org>
    <title>
      <narrative>Reducing TB incidence and TB related mortality among Somalis - Somalia (01-Jan-2024-31-Dec-2026)</narrative>
    </title>
    <description type="1">
      <narrative>Somalia, Tuberculosis, World Vision International</narrative>
    </description>
    <description type="2">
      <narrative>Goal: The reduce the TB incidence from 250/100,000 in 2021 to 190/100,000 in 2026. Objectives: The goal is to increase TB case notification from the current 17,422 tin 2021 to 26,966 in 2026, and maintain treatment success rate of 90% by end of 2026; To increase the number of RR/MDR TB cases enrolled on treatment from 345 in 2022 to 1047 in 2026; To increase the treatment success rate of RR/MDR TB from 78% in the cohort of 2020 to &gt;85% in the cohort of 2024; To increase number of all diagnosed TB patients are tested for HIV and are aware of their HIV status, and to increase the proportion of TB/HIV coinfected patients on ART from the current 84% to above 90% by 2026.</narrative>
    </description>
    <participating-org ref="47045" type="30" role="1" crs-channel-code="47045">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </participating-org>
    <participating-org type="21" role="2" crs-channel-code="21000">
      <narrative>World Vision International</narrative>
    </participating-org>
    <participating-org type="21" role="4" crs-channel-code="21000">
      <narrative>World Vision International</narrative>
    </participating-org>
    <other-identifier ref="SOM-T-WVP05" type="A1">
      <owner-org ref="47045">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </owner-org>
    </other-identifier>
    <activity-status code="2" />
    <activity-date type="1" iso-date="2024-01-01" />
    <activity-date type="2" iso-date="2024-01-01" />
    <activity-date type="3" iso-date="2026-12-31" />
    <contact-info type="1">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Communications</narrative>
      </department>
      <telephone>+41 58 791 1700</telephone>
      <email>website@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <contact-info type="2">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Grant Management Division</narrative>
      </department>
      <person-name>
        <narrative>Amélie Joubert</narrative>
      </person-name>
      <job-title>
        <narrative>Fund Portfolio Manager</narrative>
      </job-title>
      <telephone>+41 58 791 1700</telephone>
      <email>amelie.joubert@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <activity-scope code="4" />
    <recipient-country code="SO" percentage="100">
      <narrative>Somalia</narrative>
    </recipient-country>
    <sector vocabulary="1" code="12263" percentage="73.54">
      <narrative>Tuberculosis</narrative>
    </sector>
    <sector vocabulary="1" code="12110" percentage="26.46">
      <narrative>Multicomponent, RSSH</narrative>
    </sector>
    <tag vocabulary="2" code="3">
      <narrative>Ensure healthy lives and promote well-being for all at all ages</narrative>
    </tag>
    <tag vocabulary="3" code="3.3">
      <narrative>End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases</narrative>
    </tag>
    <tag vocabulary="3" code="3.8">
      <narrative>Achieve universal health coverage</narrative>
    </tag>
    <country-budget-items vocabulary="4">
      <budget-item code="cd09d6c8-13e6-412e-a54d-84c32d99a370" percentage="2.78">
        <description>
          <narrative>Multicomponent -&gt; Program management -&gt; Coordination and management of national disease control programs</narrative>
        </description>
      </budget-item>
      <budget-item code="43337786-bfab-487f-b388-9fbe8808948d" percentage="21.95">
        <description>
          <narrative>Multicomponent -&gt; Program management -&gt; Grant management</narrative>
        </description>
      </budget-item>
      <budget-item code="2c341d5c-b46c-47a9-9aff-2700be47f75e" percentage="1.06">
        <description>
          <narrative>RSSH -&gt; RSSH: Monitoring and evaluation systems -&gt; Analyses, evaluations, reviews and data use</narrative>
        </description>
      </budget-item>
      <budget-item code="f94cd008-2af3-49cf-9149-7be7cf0228e7" percentage="0.24">
        <description>
          <narrative>RSSH -&gt; RSSH: Monitoring and evaluation systems -&gt; Data quality</narrative>
        </description>
      </budget-item>
      <budget-item code="42e7a4b3-fa75-4c16-8a4d-110492b156f4" percentage="0.43">
        <description>
          <narrative>RSSH -&gt; RSSH: Monitoring and evaluation systems -&gt; Routine reporting</narrative>
        </description>
      </budget-item>
      <budget-item code="fd4720c3-77e8-4b8a-8c90-69c1ae68c5e7" percentage="0.01">
        <description>
          <narrative>Tuberculosis -&gt; Collaboration with other providers and sectors -&gt; Collaboration with other programs/sectors</narrative>
        </description>
      </budget-item>
      <budget-item code="95211519-fdf1-4ae4-964d-27e8afa798cf" percentage="1.06">
        <description>
          <narrative>Tuberculosis -&gt; Collaboration with other providers and sectors -&gt; Community-based TB/DR-TB care</narrative>
        </description>
      </budget-item>
      <budget-item code="1da38701-f878-40c8-aeaf-621a89991324" percentage="1.4">
        <description>
          <narrative>Tuberculosis -&gt; Collaboration with other providers and sectors -&gt; Private provider engagement in TB/DR-TB care</narrative>
        </description>
      </budget-item>
      <budget-item code="ea39b4f6-cd94-4310-b181-394f794f9144" percentage="5.77">
        <description>
          <narrative>Tuberculosis -&gt; Drug-resistant (DR)-TB diagnosis, treatment and care -&gt; DR-TB diagnosis/drug susceptibility testing (DST)</narrative>
        </description>
      </budget-item>
      <budget-item code="5b20da70-c625-405c-858b-6de52626ae46" percentage="3.86">
        <description>
          <narrative>Tuberculosis -&gt; Drug-resistant (DR)-TB diagnosis, treatment and care -&gt; DR-TB treatment, care and support</narrative>
        </description>
      </budget-item>
      <budget-item code="99700b2a-3a9a-4855-b789-986d7a150e52" percentage="5.63">
        <description>
          <narrative>Tuberculosis -&gt; Key and vulnerable populations (KVP) - TB/DR-TB -&gt; KVP - Children and adolescents</narrative>
        </description>
      </budget-item>
      <budget-item code="23608000-3108-4c67-92d0-b1a31eb68b3f" percentage="0.12">
        <description>
          <narrative>Tuberculosis -&gt; Removing human rights and gender related barriers to TB services -&gt; Eliminating TB-related stigma and discrimination</narrative>
        </description>
      </budget-item>
      <budget-item code="f50f08b4-b9d9-4b4a-a8b2-065858f9ce31" percentage="9.06">
        <description>
          <narrative>Tuberculosis -&gt; TB diagnosis, treatment and care -&gt; TB screening and diagnosis</narrative>
        </description>
      </budget-item>
      <budget-item code="003bd5ec-d813-43cd-9bae-ec060870a2c4" percentage="44.7">
        <description>
          <narrative>Tuberculosis -&gt; TB diagnosis, treatment and care -&gt; TB treatment, care and support</narrative>
        </description>
      </budget-item>
      <budget-item code="7332ed72-b538-4ab5-b90e-f820e56c0c5b" percentage="0.79">
        <description>
          <narrative>Tuberculosis -&gt; TB/DR-TB Prevention -&gt; Infection prevention and control (IPC)</narrative>
        </description>
      </budget-item>
      <budget-item code="897b3d08-9a6f-4d26-89e2-f762e49dad11" percentage="0.3">
        <description>
          <narrative>Tuberculosis -&gt; TB/DR-TB Prevention -&gt; Preventive treatment</narrative>
        </description>
      </budget-item>
      <budget-item code="68262ac7-05ab-4aec-9c9e-320d5883c55c" percentage="0">
        <description>
          <narrative>Tuberculosis -&gt; TB/DR-TB Prevention -&gt; Screening/testing for TB infection</narrative>
        </description>
      </budget-item>
      <budget-item code="8f363382-1b81-4d2d-a396-2be1435016f2" percentage="0.68">
        <description>
          <narrative>Tuberculosis -&gt; TB/HIV -&gt; TB/HIV - Collaborative interventions</narrative>
        </description>
      </budget-item>
      <budget-item code="7c7a7505-bdfe-4146-976c-78a03ca0d545" percentage="0.09">
        <description>
          <narrative>Tuberculosis -&gt; TB/HIV -&gt; TB/HIV - Screening, testing and diagnosis</narrative>
        </description>
      </budget-item>
      <budget-item code="c03db068-1593-4995-bf69-fe67549bd239" percentage="0.07">
        <description>
          <narrative>Tuberculosis -&gt; TB/HIV -&gt; TB/HIV - Treatment and care</narrative>
        </description>
      </budget-item>
    </country-budget-items>
    <collaboration-type code="1" />
    <default-flow-type code="10" />
    <default-finance-type code="110" />
    <default-aid-type code="C01" vocabulary="1" />
    <default-tied-status code="5" />
    <budget type="2" status="2">
      <period-start iso-date="2024-01-01" />
      <period-end iso-date="2024-12-31" />
      <value currency="USD" value-date="2024-01-01">9742224.53</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2025-01-01" />
      <period-end iso-date="2025-12-31" />
      <value currency="USD" value-date="2025-01-01">10116771.31</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2026-01-01" />
      <period-end iso-date="2026-12-31" />
      <value currency="USD" value-date="2026-01-01">7107771.18</value>
    </budget>
    <capital-spend percentage="5.39" />
    <transaction ref="131e6a89-61a8-42eb-975b-a17ac0cd8316">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-12-20" />
      <value currency="USD" value-date="2023-12-20">14047887.53</value>
      <description>
        <narrative>Global Fund commitment to SOM-T-WVP05.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="440b5112-7a76-4356-a1e5-af400c7c8921">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-01-04" />
      <value currency="USD" value-date="2024-01-04">1918069.00</value>
      <description>
        <narrative>Global Fund disbursement to SOM-T-WVP05 (International NGO).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="bf0fb271-f49a-4207-b8bb-a63caee61401">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-04-29" />
      <value currency="USD" value-date="2024-04-29">595340.00</value>
      <description>
        <narrative>Global Fund disbursement to SOM-T-WVP05 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="ec844d47-5c05-408b-a682-d7d5e01f42aa">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-04-29" />
      <value currency="USD" value-date="2024-04-29">926968.43</value>
      <description>
        <narrative>Global Fund disbursement to SOM-T-WVP05 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="1f2f0306-83ca-48f8-8ea4-c865a5fe66f9">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-07-11" />
      <value currency="USD" value-date="2024-07-11">3233054.00</value>
      <description>
        <narrative>Global Fund disbursement to SOM-T-WVP05 (International NGO).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="5a7f5aae-80a9-4991-afc8-9096831020ca">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-07-11" />
      <value currency="USD" value-date="2024-07-11">666046.91</value>
      <description>
        <narrative>Global Fund disbursement to SOM-T-WVP05 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="92f668f3-c627-43d0-98a8-33e2ff89d633">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-07-11" />
      <value currency="USD" value-date="2024-07-11">172791.33</value>
      <description>
        <narrative>Global Fund disbursement to SOM-T-WVP05 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="f2fc9a98-6dcd-48fb-82e6-d823aae58a66">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-10-03" />
      <value currency="USD" value-date="2024-10-03">715583.67</value>
      <description>
        <narrative>Global Fund disbursement to SOM-T-WVP05 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="2265d3f4-b389-4908-8f4c-991c55cc0609">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-11-26" />
      <value currency="USD" value-date="2024-11-26">1900175.74</value>
      <description>
        <narrative>Global Fund disbursement to SOM-T-WVP05 (International NGO).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="2760b7d1-c417-4e06-9215-61e9f64f94cb">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-11-26" />
      <value currency="USD" value-date="2024-11-26">1069051.03</value>
      <description>
        <narrative>Global Fund disbursement to SOM-T-WVP05 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="bbbd4fa6-f86e-48bd-95c0-d96bc0ad33b8">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-11-26" />
      <value currency="USD" value-date="2024-11-26">166646.73</value>
      <description>
        <narrative>Global Fund disbursement to SOM-T-WVP05 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="37fec16f-b810-45ef-9893-e9392eba1178">
      <transaction-type code="7" />
      <transaction-date iso-date="2024-12-01" />
      <value currency="USD" value-date="2024-12-01">103.00</value>
      <description>
        <narrative>Funds returned to the Global Fund from SOM-T-WVP05 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="21">
        <narrative>World Vision International</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="4321f402-9478-4d85-9897-1d3ef235f966">
      <transaction-type code="7" />
      <transaction-date iso-date="2024-12-04" />
      <value currency="USD" value-date="2024-12-04">37598.38</value>
      <description>
        <narrative>Funds returned to the Global Fund from SOM-T-WVP05 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="21">
        <narrative>World Vision International</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="08a7739d-4fe7-420e-a0fd-b736b48a2e33">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-12-16" />
      <value currency="USD" value-date="2024-12-16">-37598.38</value>
      <description>
        <narrative>Global Fund commitment to SOM-T-WVP05.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="83be7609-47cb-4702-b884-a26797231504">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-12-16" />
      <value currency="USD" value-date="2024-12-16">-103.00</value>
      <description>
        <narrative>Global Fund commitment to SOM-T-WVP05.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="139519a2-853b-464b-9820-af34a743faa0">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-01-28" />
      <value currency="USD" value-date="2025-01-28">1750454.78</value>
      <description>
        <narrative>Global Fund disbursement to SOM-T-WVP05 (International NGO).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="78cfbeea-b9cc-4d2d-a8f4-768fad0abde9">
      <transaction-type code="7" />
      <transaction-date iso-date="2025-03-01" />
      <value currency="USD" value-date="2025-03-01">80887.29</value>
      <description>
        <narrative>Funds returned to the Global Fund from SOM-T-WVP05 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="21">
        <narrative>World Vision International</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="6fd0ad83-c2eb-4c41-8478-241950860868">
      <transaction-type code="7" />
      <transaction-date iso-date="2025-03-07" />
      <value currency="USD" value-date="2025-03-07">3679.94</value>
      <description>
        <narrative>Funds returned to the Global Fund from SOM-T-WVP05 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="21">
        <narrative>World Vision International</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="2f1208f7-12fe-4bbc-a124-efd246a6742e">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-03-20" />
      <value currency="USD" value-date="2025-03-20">105884.00</value>
      <description>
        <narrative>Global Fund disbursement to SOM-T-WVP05 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="b870c461-7397-456d-99e2-2a9036b57c39">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-03-26" />
      <value currency="USD" value-date="2025-03-26">-3679.94</value>
      <description>
        <narrative>Global Fund commitment to SOM-T-WVP05.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="eaa78686-9fec-4676-821f-12a4aaa8e275">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-03-26" />
      <value currency="USD" value-date="2025-03-26">-80887.29</value>
      <description>
        <narrative>Global Fund commitment to SOM-T-WVP05.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="2eaba8d6-3286-45fe-b3be-8d99515ccdf2">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-05-05" />
      <value currency="USD" value-date="2025-05-05">827821.91</value>
      <description>
        <narrative>Global Fund disbursement to SOM-T-WVP05 (International NGO).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="5200d394-4e4d-4cbd-a1a3-4a67844fac00">
      <transaction-type code="7" />
      <transaction-date iso-date="2025-06-01" />
      <value currency="USD" value-date="2025-06-01">13563.19</value>
      <description>
        <narrative>Funds returned to the Global Fund from SOM-T-WVP05 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="21">
        <narrative>World Vision International</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="4316008b-fa13-48e4-82cb-057f5737ecb2">
      <transaction-type code="7" />
      <transaction-date iso-date="2025-06-05" />
      <value currency="USD" value-date="2025-06-05">41.63</value>
      <description>
        <narrative>Funds returned to the Global Fund from SOM-T-WVP05 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="21">
        <narrative>World Vision International</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="83a8c143-bb6e-4a08-bfe7-83fb5ed1d503">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-06-05" />
      <value currency="USD" value-date="2025-06-05">827987.44</value>
      <description>
        <narrative>Global Fund commitment to SOM-T-WVP05.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="5767ac68-d76a-46e2-8fb5-d1137bfb43e6">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-06-06" />
      <value currency="USD" value-date="2025-06-06">-13563.19</value>
      <description>
        <narrative>Global Fund commitment to SOM-T-WVP05.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="83c872e0-4213-451a-88b1-96330128470e">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-06-11" />
      <value currency="USD" value-date="2025-06-11">827987.44</value>
      <description>
        <narrative>Global Fund disbursement to SOM-T-WVP05 (International NGO).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="af9dd014-031e-4c66-a966-ac35770d3bb6">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-06-13" />
      <value currency="USD" value-date="2025-06-13">-41.63</value>
      <description>
        <narrative>Global Fund commitment to SOM-T-WVP05.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="69898c23-d7f1-48fa-8e98-b154966a9462">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-07-04" />
      <value currency="USD" value-date="2025-07-04">4840573.00</value>
      <description>
        <narrative>Global Fund commitment to SOM-T-WVP05.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="c8587bb4-c75c-4ea9-9c23-4f5e238cfc44">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-07-08" />
      <value currency="USD" value-date="2025-07-08">1084013.00</value>
      <description>
        <narrative>Global Fund disbursement to SOM-T-WVP05 (International NGO).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="488597f5-122d-44cf-95cb-263d6a09a813">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-07-22" />
      <value currency="USD" value-date="2025-07-22">837893.91</value>
      <description>
        <narrative>Global Fund disbursement to SOM-T-WVP05 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="97630348-450f-4c23-9282-b3235c1e894c">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-07-22" />
      <value currency="USD" value-date="2025-07-22">80364.71</value>
      <description>
        <narrative>Global Fund disbursement to SOM-T-WVP05 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="14f108f8-11c1-4426-beb7-b40b3627b363">
      <transaction-type code="7" />
      <transaction-date iso-date="2025-09-01" />
      <value currency="USD" value-date="2025-09-01">47433.57</value>
      <description>
        <narrative>Funds returned to the Global Fund from SOM-T-WVP05 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="21">
        <narrative>World Vision International</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="4065e284-f92e-42d1-9193-d8ee1b760e0e">
      <transaction-type code="7" />
      <transaction-date iso-date="2025-09-01" />
      <value currency="USD" value-date="2025-09-01">49716.70</value>
      <description>
        <narrative>Funds returned to the Global Fund from SOM-T-WVP05 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="21">
        <narrative>World Vision International</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="f0a29ecd-c26c-4c13-b0a8-d7e21f154031">
      <transaction-type code="7" />
      <transaction-date iso-date="2025-09-02" />
      <value currency="USD" value-date="2025-09-02">1936.10</value>
      <description>
        <narrative>Funds returned to the Global Fund from SOM-T-WVP05 (International NGO).</narrative>
      </description>
      <provider-org type="21">
        <narrative>World Vision International</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="aa47bdfc-09c2-416a-a2a5-9e2c845ad64d">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-09-10" />
      <value currency="USD" value-date="2025-09-10">-47433.57</value>
      <description>
        <narrative>Global Fund commitment to SOM-T-WVP05.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="30e8444a-0ab2-4f17-aaa6-ab7cef628dd2">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-09-15" />
      <value currency="USD" value-date="2025-09-15">-49716.70</value>
      <description>
        <narrative>Global Fund commitment to SOM-T-WVP05.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="1f4b796d-e6db-43bd-879a-9296d8181d89">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-09-22" />
      <value currency="USD" value-date="2025-09-22">-1936.10</value>
      <description>
        <narrative>Global Fund commitment to SOM-T-WVP05.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="a87fd299-7533-43ec-9bc8-17ad95785536">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-10-21" />
      <value currency="USD" value-date="2025-10-21">2680596.59</value>
      <description>
        <narrative>Global Fund disbursement to SOM-T-WVP05 (International NGO).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="322748fc-35ca-43ce-9ec2-4c1d804782b3">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-11-28" />
      <value currency="USD" value-date="2025-11-28">-157704.79</value>
      <description>
        <narrative>Global Fund commitment to SOM-T-WVP05.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="a9abce61-f791-45a2-8a65-1eae525e1b22">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-11-28" />
      <value currency="USD" value-date="2025-11-28">4553196.16</value>
      <description>
        <narrative>Global Fund commitment to SOM-T-WVP05.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="81e55a17-bb78-48ab-9222-16ecf689cad1">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-12-02" />
      <value currency="USD" value-date="2025-12-02">481409.08</value>
      <description>
        <narrative>Global Fund disbursement to SOM-T-WVP05 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="949313f5-3046-4c43-a207-31c546ccd062">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-12-02" />
      <value currency="USD" value-date="2025-12-02">300000.00</value>
      <description>
        <narrative>Global Fund disbursement to SOM-T-WVP05 (International NGO).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="a9039c66-0611-4248-901a-4359993f279b">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-12-02" />
      <value currency="USD" value-date="2025-12-02">48355.86</value>
      <description>
        <narrative>Global Fund disbursement to SOM-T-WVP05 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="fc497115-bcd0-4621-a1bd-ada7d2d0ab1f">
      <transaction-type code="7" />
      <transaction-date iso-date="2025-12-05" />
      <value currency="USD" value-date="2025-12-05">103.00</value>
      <description>
        <narrative>Funds returned to the Global Fund from SOM-T-WVP05 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="21">
        <narrative>World Vision International</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="c1f857a8-307d-4c9b-9149-74722c56e3a5">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-12-16" />
      <value currency="USD" value-date="2025-12-16">-103.00</value>
      <description>
        <narrative>Global Fund commitment to SOM-T-WVP05.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="88d80ca5-9c25-4489-8125-66289ba964a5">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-02-17" />
      <value currency="USD" value-date="2026-02-17">1327255.95</value>
      <description>
        <narrative>Global Fund disbursement to SOM-T-WVP05 (International NGO).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="3d59c8da-f578-4d88-a927-afd9f86653ae">
      <transaction-type code="7" />
      <transaction-date iso-date="2026-03-01" />
      <value currency="USD" value-date="2026-03-01">83962.60</value>
      <description>
        <narrative>Funds returned to the Global Fund from SOM-T-WVP05 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="21">
        <narrative>World Vision International</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="509bbe2c-e157-4f23-b717-51ba92d88db8">
      <transaction-type code="7" />
      <transaction-date iso-date="2026-03-09" />
      <value currency="USD" value-date="2026-03-09">4037.30</value>
      <description>
        <narrative>Funds returned to the Global Fund from SOM-T-WVP05 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="21">
        <narrative>World Vision International</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="89320fe6-b390-4d34-b64b-1d433b6a2e39">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-03-12" />
      <value currency="USD" value-date="2026-03-12">-83962.60</value>
      <description>
        <narrative>Global Fund commitment to SOM-T-WVP05.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="e48d8b9c-72b5-49de-9b8f-fff61c8ee7d9">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-03-17" />
      <value currency="USD" value-date="2026-03-17">-4037.30</value>
      <description>
        <narrative>Global Fund commitment to SOM-T-WVP05.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="d24f1c60-c6db-47c7-afa0-e381bd2f1d86">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-05-19" />
      <value currency="USD" value-date="2026-05-19">352888.78</value>
      <description>
        <narrative>Global Fund disbursement to SOM-T-WVP05 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="dff40c9a-606d-4b01-aeff-ba713756a608">
      <transaction-type code="7" />
      <transaction-date iso-date="2026-06-01" />
      <value currency="USD" value-date="2026-06-01">51226.18</value>
      <description>
        <narrative>Funds returned to the Global Fund from SOM-T-WVP05 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="21">
        <narrative>World Vision International</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="b8fd5276-bb02-4efd-bfe5-418b62c6b8d1">
      <transaction-type code="7" />
      <transaction-date iso-date="2026-06-04" />
      <value currency="USD" value-date="2026-06-04">15472.65</value>
      <description>
        <narrative>Funds returned to the Global Fund from SOM-T-WVP05 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="21">
        <narrative>World Vision International</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="2b2108f7-12c9-4162-ae43-e33595e7f71f">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-06-08" />
      <value currency="USD" value-date="2026-06-08">-51226.18</value>
      <description>
        <narrative>Global Fund commitment to SOM-T-WVP05.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="90b5dee4-5d4e-409f-ba74-a3f4f0200e69">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-06-19" />
      <value currency="USD" value-date="2026-06-19">-15472.65</value>
      <description>
        <narrative>Global Fund commitment to SOM-T-WVP05.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="01974722-de6e-4994-98ba-900453f24875">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-08-05" />
      <value currency="USD" value-date="2026-08-05">-2043286.49</value>
      <description>
        <narrative>Global Fund commitment to SOM-T-WVP05.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="38f8f478-547b-4002-891f-c9028ec44aff">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-08-05" />
      <value currency="USD" value-date="2026-08-05">3652404.49</value>
      <description>
        <narrative>Global Fund commitment to SOM-T-WVP05.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="5efcbee5-e3b3-4b96-86e9-f3a65b54876e">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-08-11" />
      <value currency="USD" value-date="2026-08-11">1445463.82</value>
      <description>
        <narrative>Global Fund disbursement to SOM-T-WVP05 (International NGO).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="abde4246-62bf-4f75-bf2c-96e3fee8dd54">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-09-22" />
      <value currency="USD" value-date="2026-09-22">680270.16</value>
      <description>
        <narrative>Global Fund disbursement to SOM-T-WVP05 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="0fe1bfed-fe38-4e2b-bb48-096b744189b4">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-11-10" />
      <value currency="USD" value-date="2026-11-10">327258.51</value>
      <description>
        <narrative>Global Fund disbursement to SOM-T-WVP05 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="21">
        <narrative>World Vision International</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="SOM-T-WVP05-EXP-20241231">
      <transaction-type code="4" />
      <transaction-date iso-date="2024-12-31" />
      <value currency="USD" value-date="2024-12-31">9742224.54</value>
      <description>
        <narrative>Expenditure reported by World Vision International for SOM-T-WVP05, Jan 2024 to Dec 2024.</narrative>
      </description>
      <provider-org type="21">
        <narrative>World Vision International</narrative>
      </provider-org>
    </transaction>
    <transaction ref="SOM-T-WVP05-EXP-20251231">
      <transaction-type code="4" />
      <transaction-date iso-date="2025-12-31" />
      <value currency="USD" value-date="2025-12-31">8136672.05</value>
      <description>
        <narrative>Expenditure reported by World Vision International for SOM-T-WVP05, Jan 2025 to Dec 2025.</narrative>
      </description>
      <provider-org type="21">
        <narrative>World Vision International</narrative>
      </provider-org>
    </transaction>
    <document-link url="https://data.theglobalfund.org/grant/SOM-T-WV" format="text/html">
      <title>
        <narrative>Grant page on the data explorer of the Global Fund.</narrative>
      </title>
      <description>
        <narrative>An overview of a grant over its lifetime.</narrative>
      </description>
      <category code="A12" />
      <category code="A01" />
      <category code="A02" />
      <category code="A05" />
      <category code="A07" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2026-11-11" />
    </document-link>
    <document-link url="https://www.theglobalfund.org/media/13342/core_grantregulationsversiontwo_regulations_en.pdf" format="application/pdf">
      <title>
        <narrative>Grant terms and conditions.</narrative>
      </title>
      <description>
        <narrative>General terms and conditions which apply to Global Fund grants.</narrative>
      </description>
      <category code="A04" />
      <language code="en" />
    </document-link>
    <document-link url="https://docs.theglobalfund.org/files/Applications/Funding Requests/SOM/2023/Tuberculosis/en/SOM-T_FundingRequest_1_en.zip" format="application/zip">
      <title>
        <narrative>2023 - Funding Request - Window 2 - Tuberculosis - Somalia - English</narrative>
      </title>
      <description>
        <narrative>Funding Request of funding request FR1452-SOM-T.</narrative>
      </description>
      <category code="A01" />
      <category code="A02" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2023-05-30" />
    </document-link>
    <conditions attached="1">
      <condition type="1">
        <narrative>1 - Personal Data (1) Principles. The Principal Recipient, acknowledges that Program Activities are expected to respect the following principles and rights (“Data Protection Principles”): (a) Information that could be used to identify a natural person (“Personal Data”) will be: (i) processed lawfully, fairly and transparently; (ii) collected for specified, explicit and legitimate purposes and not further processed in a manner not compatible with those purposes;  (iii) adequate, relevant and limited to what is necessary for the purposes for which they are processed; (iv) accurate and, where necessary, kept up to date; (v) kept in a form which permits identification of the individuals for no longer than is necessary for the purposes for which the Personal Data is processed; and (vi) processed in a manner that ensures appropriate security of the Personal Data; and (b) Natural persons are afforded, where relevant, the right to information about Personal Data that is processed; the right to access and rectify or erase Personal Data; the right to data portability; the right to confidentiality of electronic communications; and the right to object to processing. (2) Limitations. Where collection and processing of Personal Data is required in order to implement Program Activities, whether by the Principal Recipient, a Sub-recipient, or Supplier, the Principal Recipient should respect the Data Protection Principles: (a) to the extent that doing so does not violate or conflict with applicable law and/or policy; and (b) subject to the Principal Recipient balancing the Data Protection Principles with other fundamental rights in accordance with the principle of proportionality, taking into account the risks to the rights and freedoms of natural persons.</narrative>
      </condition>
      <condition type="1">
        <narrative>2 - With respect to Section 7.6 (Right of Access) of the Global Fund Grant Regulations (as amended from time to time), (1) the Global Fund may collect or seek to collect data, and it is possible that such data may contain Personal Data, and (2), prior to collection and at all times thereafter, the Principal Recipient shall take all necessary actions to ensure that the transfer of such information to the Global Fund does not violate any applicable law or regulation.</narrative>
      </condition>
      <condition type="1">
        <narrative>3 - (1) In accordance with the Global Fund’s Sustainability, Transition and Co-financing Policy (GF/B35/04) (the “STC Policy”), the commitment and disbursement of [USD/EUR … [based on % communicated in the Allocation Letter for the relevant disease component(s)]] (the “Co-Financing Incentive”), is subject to the Global Fund’s satisfaction with the Host Country’s compliance with the requirements listed at X.X(1)(a) and X.X(1)(b) below (“Co-Financing Requirements”). The Grantee acknowledges and agrees that the Global Fund may reduce Grant Funds during the current or any subsequent Implementation Period in the event the Host Country fails to: (a) [maintain or] progressively increase government expenditure on health to meet national universal health coverage goals; and/or (b) [maintain or] increase domestic funding of Global Fund-supported programs, with a focus on progressively absorbing the key costs of national disease plans, as identified in consultation with the Global Fund. (2) In order to satisfy the Co-Financing Requirements, the Grantee acknowledges and agrees that the Host Country shall, as set out in [Commitment Letter description, dated DD/MMM/YYYY (the “Commitment Letter”)], unless otherwise agreed in writing with the Global Fund: (a) fulfil a total minimum co-financing commitment of [USD/EUR … from 20XX-20YY] (inclusive), comprising investments in: i. [HIV of USD/EUR …;] ii. [TB of USD/EUR …;] iii. [Malaria of USD/EUR …; and] iv. [RSSH of USD/EUR …;] [and] (b) [fulfil the programmatic commitments as stipulated in [Section [x] of] the Commitment Letter; and] (c) provide to the Global Fund, by no later than [agreed date in Commitment Letter] of each year of the Implementation Period and the year following the end of the Implementation Period, evidence supporting achievement of the Co-Financing Requirements, including: i. the approved annual budget for [HIV / TB / Malaria / RSSH] for the upcoming year; [and] ii. the total expenditure for [HIV / TB / Malaria / RSSH] in the previous fiscal year[.][; and] iii. [insert any other requirements that are set out in the Commitment Letter].</narrative>
      </condition>
      <condition type="2">
        <narrative>4 - The Program budget may be funded in part by Grant Funds disbursed under a previous Grant Agreement, which the Global Fund has approved to be used for the Program under the current Grant Agreement (“Previously Disbursed Grant Funds”), as well as additional Grant Funds up to the amount set forth in Section 3.6. hereof. Accordingly, the Global Fund may reduce the amount of Grant Funds set forth in Section 3.6. hereof by the amount of any Previously Disbursed Grant Funds. Previously Disbursed Grant Funds shall be governed by the terms of this Grant Agreement.</narrative>
      </condition>
      <condition type="1">
        <narrative>5 - The Principal Recipient shall ensure that: (1) it and any Sub-recipient or Supplier: (a) complies with applicable Economic Sanctions Law, including by, as applicable, not entering into any agreement or transaction, or engaging in activities with or for the benefit of any sanctioned individual or entity, or involving any sanctioned country or territory, except as permitted under Economic Sanctions Law applicable to the Principal Recipient, any Grant Sub-recipient or Supplier, the Use of Grant Funds or implementation of Program Activities; or (b) engage in, transact or otherwise facilitate any export, transfer or transmission of goods, services, software, technical data or technology in violation of any applicable regulations, laws or legally binding measures. Economic Sanctions Law referred to in this sub-section are defined as follows: “Economic Sanctions Law” means any economic or financial sanctions administered by the Office of Foreign Assets Control of the United States Department of the Treasury (“OFAC”), the United States State Department, any other agency of the United States government, the United Nations, the United Kingdom, the European Union or any member state thereof, and/or Switzerland; (2) it and any Sub-recipients or Suppliers have reasonable controls in place to ensure compliance with sub-section (1) above (including, without limitation, verifying that counterparties are not designated by applicable Economic Sanctions Law before requesting quotations from them and having robust contractual provisions in place with Sub-recipients and Suppliers regarding compliance with applicable Economic Sanctions Law); and (3) the Global Fund is promptly notified in writing of any act or omission materially inconsistent with the requirements of this sub-section. (5) Notwithstanding the provisions of the Global Fund Guidelines for Grant Budgeting or any discretion otherwise afforded to the Principal Recipient to revise the Program budget without prior written approval from the Global Fund, Grant Funds in the amount of USD 300,000, allocated for Climate and Health-related activities, shall be exclusively used for: “expansion of mobile TB diagnostic capacity (including hotspot mapping and procurement of equipment for mobile services) to enable on the spot systematic screening, identification of presumptive TB cases and diagnosis.” These funds may not be reprogrammed for any other use without the prior, written consent of the Global Fund.</narrative>
      </condition>
    </conditions>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of people with confirmed RR-TB and/or MDR-TB notified</narrative>
      </title>
      <description>
        <narrative>Module: Drug-resistant (DR)-TB diagnosis, treatment and care.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of people with confirmed RR-TB and/or MDR-TB notified</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="345" />
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target value="806" />
          <actual value="281" />
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="403" />
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="403" />
          <actual value="130" />
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="923" />
          <actual value="245" />
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="461" />
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="462" />
          <actual value="121" />
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target value="523" />
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target value="524" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of people with confirmed RR-TB and/or MDR-TB that began second-line treatment</narrative>
      </title>
      <description>
        <narrative>Module: Drug-resistant (DR)-TB diagnosis, treatment and care.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of people with confirmed RR-TB and/or MDR-TB that began second-line treatment</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="90" />
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target value="95" />
          <actual value="100">
            <comment>
              <narrative>Numerator: 281; Denominator: 281.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="95" />
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="95" />
          <actual value="100">
            <comment>
              <narrative>Numerator: 130; Denominator: 130.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="95" />
          <actual value="96.33">
            <comment>
              <narrative>Numerator: 236; Denominator: 245.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="95" />
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="95" />
          <actual value="100">
            <comment>
              <narrative>Numerator: 121; Denominator: 121.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target value="95" />
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target value="95" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Treatment success rate of RR-TB and/or MDR-TB: Percentage of patients with RR and/or MDR-TB successfully treated</narrative>
      </title>
      <description>
        <narrative>Module: Drug-resistant (DR)-TB diagnosis, treatment and care.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Treatment success rate of RR-TB and/or MDR-TB: Percentage of patients with RR and/or MDR-TB successfully treated</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="78" />
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target value="81" />
          <actual value="87.78">
            <comment>
              <narrative>Numerator: 273; Denominator: 311.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="81" />
          <actual value="87.78">
            <comment>
              <narrative>Numerator: 273; Denominator: 311.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="83" />
          <actual value="93.25">
            <comment>
              <narrative>Numerator: 290; Denominator: 311.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="83" />
          <actual value="93.25">
            <comment>
              <narrative>Numerator: 290; Denominator: 311.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target value="85" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of people with TB (all forms) notified among prisoners; *includes only those with new and relapse TB</narrative>
      </title>
      <description>
        <narrative>Module: Key and vulnerable populations (KVP) - TB/DR-TB.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of people with TB (all forms) notified among prisoners; *includes only those with new and relapse TB</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="40" />
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="50" />
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="60" />
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target value="70" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of laboratories successfully participating in external quality assurance (EQA) or proficiency testing (PT) schemes</narrative>
      </title>
      <description>
        <narrative>Module: RSSH/PP: Laboratory systems (including national and peripheral).</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of laboratories successfully participating in external quality assurance (EQA) or proficiency testing (PT) schemes</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="99">
          <comment>
            <narrative>Numerator: 92; Denominator: 93.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="99">
          <dimension name="Disease/program" value="TB" />
          <comment>
            <narrative>Numerator: 92; Denominator: 93.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="99">
          <dimension name="Disease/program" value="TB" />
          <comment>
            <narrative>Numerator: 92; Denominator: 93.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="93">
            <comment>
              <narrative>Numerator: 107; Denominator: 115.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target value="93">
            <comment>
              <narrative>Numerator: 214; Denominator: 230.</narrative>
            </comment>
          </target>
          <actual value="80.7">
            <comment>
              <narrative>Numerator: 184; Denominator: 228.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="93">
            <comment>
              <narrative>Numerator: 107; Denominator: 115.</narrative>
            </comment>
          </target>
          <actual value="89.38">
            <comment>
              <narrative>Numerator: 101; Denominator: 113.</narrative>
            </comment>
          </actual>
          <actual value="100">
            <dimension name="Disease/program" value="TB" />
            <comment>
              <narrative>Numerator: 184; Denominator: 184.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="93">
            <comment>
              <narrative>Numerator: 110; Denominator: 118.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="94.5">
            <comment>
              <narrative>Numerator: 223; Denominator: 236.</narrative>
            </comment>
          </target>
          <actual value="100">
            <comment>
              <narrative>Numerator: 86; Denominator: 86.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="96">
            <comment>
              <narrative>Numerator: 113; Denominator: 118.</narrative>
            </comment>
          </target>
          <actual value="100">
            <comment>
              <narrative>Numerator: 37; Denominator: 37.</narrative>
            </comment>
          </actual>
          <actual value="100">
            <dimension name="Disease/program" value="TB" />
            <comment>
              <narrative>Numerator: 86; Denominator: 86.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target value="98">
            <comment>
              <narrative>Numerator: 117; Denominator: 120.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target value="98">
            <comment>
              <narrative>Numerator: 117; Denominator: 120.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of molecular diagnostic analyzers achieving at least 85% functionality (ability to test samples) during the reporting period</narrative>
      </title>
      <description>
        <narrative>Module: RSSH/PP: Laboratory systems (including national and peripheral).</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of molecular diagnostic analyzers achieving at least 85% functionality (ability to test samples) during the reporting period</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative - other.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="84.68">
          <comment>
            <narrative>Numerator: 94; Denominator: 111.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="94.59">
            <comment>
              <narrative>Numerator: 105; Denominator: 111.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="94.74">
            <comment>
              <narrative>Numerator: 108; Denominator: 114.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target value="94.74">
            <comment>
              <narrative>Numerator: 108; Denominator: 114.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Completeness of reporting: Percentage of expected monthly reports (for the reporting period) that are actually received</narrative>
      </title>
      <description>
        <narrative>Module: RSSH: Monitoring and evaluation systems.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Completeness of reporting: Percentage of expected monthly reports (for the reporting period) that are actually received</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="95.37">
          <comment>
            <narrative>Numerator: 103; Denominator: 108.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target value="90.6">
            <comment>
              <narrative>Numerator: 212; Denominator: 234.</narrative>
            </comment>
          </target>
          <actual value="100">
            <comment>
              <narrative>Numerator: 456; Denominator: 456.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="90.52">
            <comment>
              <narrative>Numerator: 105; Denominator: 116.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="90.68">
            <comment>
              <narrative>Numerator: 107; Denominator: 118.</narrative>
            </comment>
          </target>
          <actual value="100.29">
            <comment>
              <narrative>Numerator: 341; Denominator: 340.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="90.4">
            <comment>
              <narrative>Numerator: 217; Denominator: 240.</narrative>
            </comment>
          </target>
          <actual value="100">
            <comment>
              <narrative>Numerator: 469; Denominator: 469.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="90">
            <comment>
              <narrative>Numerator: 108; Denominator: 120.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="90.83">
            <comment>
              <narrative>Numerator: 109; Denominator: 120.</narrative>
            </comment>
          </target>
          <actual value="100">
            <comment>
              <narrative>Numerator: 237; Denominator: 237.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target value="94.26">
            <comment>
              <narrative>Numerator: 115; Denominator: 122.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target value="98.39">
            <comment>
              <narrative>Numerator: 122; Denominator: 124.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Timeliness of reporting: Percentage of submitted monthly reports (for the reporting period) that are received on time per the national guidelines</narrative>
      </title>
      <description>
        <narrative>Module: RSSH: Monitoring and evaluation systems.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Timeliness of reporting: Percentage of submitted monthly reports (for the reporting period) that are received on time per the national guidelines</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="95">
          <comment>
            <narrative>Numerator: 103; Denominator: 108.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="95">
          <dimension name="Report type" value="TB reports" />
          <comment>
            <narrative>Numerator: 103; Denominator: 108.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="95">
          <dimension name="Report type" value="TB reports" />
          <comment>
            <narrative>Numerator: 103; Denominator: 108.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target value="90.6">
            <comment>
              <narrative>Numerator: 192; Denominator: 212.</narrative>
            </comment>
          </target>
          <actual value="100">
            <comment>
              <narrative>Numerator: 456; Denominator: 456.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="91">
            <comment>
              <narrative>Numerator: 95; Denominator: 105.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="91">
            <comment>
              <narrative>Numerator: 97; Denominator: 107.</narrative>
            </comment>
          </target>
          <actual value="100.29">
            <comment>
              <narrative>Numerator: 342; Denominator: 341.</narrative>
            </comment>
          </actual>
          <actual value="100">
            <dimension name="Report type" value="TB reports" />
            <comment>
              <narrative>Numerator: 456; Denominator: 456.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="90">
            <comment>
              <narrative>Numerator: 97; Denominator: 108.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="90.8">
            <comment>
              <narrative>Numerator: 197; Denominator: 217.</narrative>
            </comment>
          </target>
          <actual value="100">
            <comment>
              <narrative>Numerator: 469; Denominator: 469.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="90">
            <comment>
              <narrative>Numerator: 100; Denominator: 109.</narrative>
            </comment>
          </target>
          <actual value="100">
            <comment>
              <narrative>Numerator: 237; Denominator: 237.</narrative>
            </comment>
          </actual>
          <actual value="100">
            <dimension name="Report type" value="TB reports" />
            <comment>
              <narrative>Numerator: 469; Denominator: 469.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target value="94">
            <comment>
              <narrative>Numerator: 109; Denominator: 115.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target value="98">
            <comment>
              <narrative>Numerator: 120; Denominator: 122.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of patients with of all forms of TB notified (i.e., bacteriologically confirmed + clinically diagnosed); *includes only those with new and relapse TB</narrative>
      </title>
      <description>
        <narrative>Module: TB diagnosis, treatment and care.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of patients with of all forms of TB notified (i.e., bacteriologically confirmed + clinically diagnosed); *includes only those with new and relapse TB</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31">
          <comment>
            <narrative>Numerator: 18272.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 14508; Denominator: 18264; Percentage: 79%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 14508; Denominator: 18264; Percentage: 79%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 3742; Denominator: 18264; Percentage: 20%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 3742; Denominator: 18264; Percentage: 20%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Type of TB" value="Bacteriologically confirmed" />
          <comment>
            <narrative>Numerator: 8930; Denominator: 18272; Percentage: 49%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Type of TB" value="Bacteriologically confirmed" />
          <comment>
            <narrative>Numerator: 8930; Denominator: 18272; Percentage: 49%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 7903; Denominator: 18264; Percentage: 43%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 7903; Denominator: 18264; Percentage: 43%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 10347; Denominator: 18264; Percentage: 57%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 10347; Denominator: 18264; Percentage: 57%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="HIV status" value="Negative" />
          <comment>
            <narrative>Numerator: 17250; Denominator: 18272; Percentage: 94%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="HIV status" value="Negative" />
          <comment>
            <narrative>Numerator: 17250; Denominator: 18272; Percentage: 94%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="HIV status" value="Positive" />
          <comment>
            <narrative>Numerator: 199; Denominator: 18272; Percentage: 1%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="HIV status" value="Positive" />
          <comment>
            <narrative>Numerator: 199; Denominator: 18272; Percentage: 1%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="HIV status" value="Unknown" />
          <comment>
            <narrative>Numerator: 823; Denominator: 18272; Percentage: 5%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="HIV status" value="Unknown" />
          <comment>
            <narrative>Numerator: 823; Denominator: 18272; Percentage: 5%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 10688.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 21376.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 18159.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 10688.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 8922.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 15072.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 3087.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Type of TB" value="Bacteriologically confirmed" />
            <comment>
              <narrative>Numerator: 8745.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 7624.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 10535.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV status" value="Negative" />
            <comment>
              <narrative>Numerator: 17509.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV status" value="Positive" />
            <comment>
              <narrative>Numerator: 113.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV status" value="Unknown" />
            <comment>
              <narrative>Numerator: 537.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 24022.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 17883.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 12011.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 12011.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 8834.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 14702.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 3181.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Type of TB" value="Bacteriologically confirmed" />
            <comment>
              <narrative>Numerator: 9793.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 7300.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 10583.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV status" value="Negative" />
            <comment>
              <narrative>Numerator: 17515.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV status" value="Positive" />
            <comment>
              <narrative>Numerator: 85.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV status" value="Unknown" />
            <comment>
              <narrative>Numerator: 283.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 13498.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 13498.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of new and relapse TB patients tested using WHO recommended rapid diagnostic tests at the time of diagnosis</narrative>
      </title>
      <description>
        <narrative>Module: TB diagnosis, treatment and care.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of new and relapse TB patients tested using WHO recommended rapid diagnostic tests at the time of diagnosis</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="38" />
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="60" />
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target value="60" />
          <actual value="60.45">
            <comment>
              <narrative>Numerator: 10978; Denominator: 18159.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="60" />
          <actual value="47.68">
            <comment>
              <narrative>Numerator: 4254; Denominator: 8922.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="70" />
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="70" />
          <actual value="54.9">
            <comment>
              <narrative>Numerator: 9817; Denominator: 17883.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="70" />
          <actual value="53.46">
            <comment>
              <narrative>Numerator: 4723; Denominator: 8834.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target value="80" />
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target value="80" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of notified patients with all forms of TB (i.e., bacteriologically confirmed + clinically diagnosed) contributed by non-national TB program providers- private/non-governmental facilities; *includes only those with new and relapse TB</narrative>
      </title>
      <description>
        <narrative>Module: TB diagnosis, treatment and care.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Percentage of notified patients with all forms of TB (i.e., bacteriologically confirmed + clinically diagnosed) contributed by non-national TB program providers- private/non-governmental facilities; *includes only those with new and relapse TB</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31">
          <comment>
            <narrative>Percentage: 16%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Private facility type" value="Private for-profit" />
          <comment>
            <narrative>Numerator: 2894; Denominator: 18272; Percentage: 16%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Private facility type" value="Private for-profit" />
          <comment>
            <narrative>Numerator: 2894; Denominator: 18272; Percentage: 16%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target>
            <comment>
              <narrative>Percentage: 20%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Percentage: 20%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 2136; Denominator: 18159; Percentage: 11.76%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Percentage: 20%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 699; Denominator: 8922; Percentage: 7.83%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Private facility type" value="Private for-profit" />
            <comment>
              <narrative>Numerator: 2136.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target>
            <comment>
              <narrative>Percentage: 20%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Percentage: 20%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1267; Denominator: 17883; Percentage: 7.08%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Percentage: 20%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: -372; Denominator: 13559; Percentage: -2.74%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Private facility type" value="Private for-profit" />
            <comment>
              <narrative>Numerator: 1267.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target>
            <comment>
              <narrative>Percentage: 20%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target>
            <comment>
              <narrative>Percentage: 20%.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Treatment success rate- all forms: Percentage of patients with all forms of TB, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB patients notified during a specified period; *includes only those with new and relapse TB</narrative>
      </title>
      <description>
        <narrative>Module: TB diagnosis, treatment and care.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Treatment success rate- all forms: Percentage of patients with all forms of TB, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB patients notified during a specified period; *includes only those with new and relapse TB</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2021" iso-date="2021-12-31" value="90" />
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="90" />
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target value="90" />
          <actual value="94.95">
            <comment>
              <narrative>Numerator: 17455; Denominator: 18384.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="90" />
          <actual value="94.01">
            <comment>
              <narrative>Numerator: 8829; Denominator: 9392.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="90" />
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="90" />
          <actual value="93.66">
            <comment>
              <narrative>Numerator: 17186; Denominator: 18349.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="90" />
          <actual value="91.73">
            <comment>
              <narrative>Numerator: 8501; Denominator: 9267.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target value="90" />
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target value="90" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of people in contact with TB patients who began preventive therapy</narrative>
      </title>
      <description>
        <narrative>Module: TB/DR-TB Prevention.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of people in contact with TB patients who began preventive therapy</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="4472" />
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="4000" />
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target value="8000" />
          <actual value="4883" />
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="4000" />
          <actual value="2355" />
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="4000" />
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="8000" />
          <actual value="6782" />
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="4000" />
          <actual value="3314" />
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target value="4000" />
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target value="4000" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative>
      </title>
      <description>
        <narrative>Module: TB/HIV.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="84" />
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="90" />
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target value="90" />
          <actual value="90.27">
            <comment>
              <narrative>Numerator: 102; Denominator: 113.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="90" />
          <actual value="95.65">
            <comment>
              <narrative>Numerator: 44; Denominator: 46.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="90" />
          <actual value="94.12">
            <comment>
              <narrative>Numerator: 80; Denominator: 85.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="90" />
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="90" />
          <actual value="93.75">
            <comment>
              <narrative>Numerator: 45; Denominator: 48.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target value="90" />
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target value="90" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of people living with HIV newly initiated on ART who were screened for TB</narrative>
      </title>
      <description>
        <narrative>Module: TB/HIV.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of people living with HIV newly initiated on ART who were screened for TB</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="62" />
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target value="90" />
          <actual value="100">
            <comment>
              <narrative>Numerator: 504; Denominator: 504.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="90" />
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="90" />
          <actual value="117.63">
            <comment>
              <narrative>Numerator: 487; Denominator: 414.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="90" />
          <actual value="100">
            <comment>
              <narrative>Numerator: 464; Denominator: 464.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="90" />
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="90" />
          <actual value="100">
            <comment>
              <narrative>Numerator: 219; Denominator: 219.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target value="90" />
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target value="90" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of registered new and relapse TB patients with documented HIV status</narrative>
      </title>
      <description>
        <narrative>Module: TB/HIV.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of registered new and relapse TB patients with documented HIV status</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="89" />
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target value="100" />
          <actual value="95.08">
            <comment>
              <narrative>Numerator: 17266; Denominator: 18159.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="100" />
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="100" />
          <actual value="96.21">
            <comment>
              <narrative>Numerator: 8584; Denominator: 8922.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="100" />
          <actual value="98.42">
            <comment>
              <narrative>Numerator: 17600; Denominator: 17883.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="100" />
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="100" />
          <actual value="98.79">
            <comment>
              <narrative>Numerator: 8727; Denominator: 8834.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target value="100" />
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target value="100" />
        </period>
      </indicator>
    </result>
  </iati-activity>
</iati-activities>